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ABSTRACT	
Adaptive immune maturation in children is likely the result of a complex 
interplay between both intrinsic and environmental factors, but surprisingly 
little is known about how early life immune maturation is related to immune 
responses and subsequent development of allergic disease. The aim of the 
FARMFLORA birth-cohort study, including farmers’ and non-farmers’ 
children, was to visualize longitudinal patterns of adaptive immune 
maturation in relation to allergic sensitization and disease, vaccine-induced 
antibody responses, as well as to certain environmental factors in childhood.  
 
By the use of multivariate factor analyses, we show that higher proportions of 
circulating neonatal regulatory T cells was strongly associated with 
sensitization in early childhood, and that a sustained higher fraction of these 
cells related to allergic disease at school age. Allergic disease at this age was 
also associated with higher proportions of naïve CD45RA+ T cells in infancy 
and with higher proportions of immature/naïve CD5+ B cells from birth to 8 
years of age. These results indicate that allergic disease in childhood is 
preceded by a heightened immaturity in the adaptive immune system. 
Further, growing up on a dairy farm was associated with a higher degree of 
adaptive immune maturation, which may in part explain the lower incidence 
of allergic disease among farmers’ children.  
 
We further found that higher antibody levels induced by the non-live vaccine 
against diphtheria, tetanus and pertussis was associated with increased 
baseline immune maturation prior to vaccination. In contrast, higher 
antibody levels induced by the live attenuated vaccine against measles, 
mumps and rubella were generally associated with a lower degree of baseline 
adaptive immune maturation. Differences in the formulations of these 
vaccines and their respective way to induce immune responses in the host 
may be a possible explanation for these diverging association patterns.  
 
Keywords: Adaptive immune maturation, children, allergic disease, farm, 
vaccine responses, prospective birth-cohort, multivariate factor analysis 
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POPULÄRVETENSKAPLIG	
SAMMANFATTNING		
Vårt immunsystem finns till för att försvara oss mot infektioner orsakade av 
mikroorganismer, till exempel bakterier och virus. Immunsystemet består av 
många olika typer av vita blodkroppar, så kallade immunceller, som var och 
en fyller en viktig funktion. I den här avhandlingen har jag framförallt 
studerat två typer av immunceller, B-celler och T-celler. Dessa celler har en 
enastående förmåga att känna igen och komma ihåg eventuella inkräktare. 
B-cellernas huvuduppgift är att producera ett sorts målsökande protein, så 
kallade antikroppar, som binder till ytan av mikroorganismer och signalerar 
till immunsystemets övriga celler att dessa ska förstöras. T-cellerna produ-
cerar istället budbärarmolekyler, så kallade cytokiner, som är viktiga för att 
styra och koordinera immunsystemet så att en eventuell inkräktare kan 
oskadliggöras effektivt. Den T- eller B-cell som vid en infektion känner igen 
en inkräktare, har förutsättning att bli aktiverad och då påbörjas även en 
mognadsprocess i cellen. Ju fler bakterier och virus immunsystemet stöter på, 
desto mer ”moget” blir det. Detta innebär att immunsystemet hos en vuxen 
individ generellt sett är betydligt mer moget och effektivt än immunsystemet 
hos ett litet barn. Man har dock sett att ”mognadsgraden” av immunsystemet 
inte bara är kopplat till ålder, utan också till vilken miljö man lever i. Man vet 
till exempel att barn i utvecklingsländer, där det generellt sett är en högre 
exponering för olika mikroorganismer, har ett mer moget immunsystem än 
jämnåriga barn i industrialiserade länder.  
Under senare hälften av 1900-talet ökade förekomsten av allergier 
dramatiskt i Sverige och i andra industrialiserade länder. Man vet inte exakt 
varför vissa barn drabbas, men mycket tyder på att uppväxtmiljön utgör en 
viktig faktor. Flera vetenskapliga studier har visat att barn som växer upp på 
bondgård med mjölkkor har en betydligt lägre risk att utveckla allergi än 
andra barn. Allergi är en immunologisk sjukdom och enligt den så kallade 
hygienhypotesen beror den ökade allergiförekomsten på att små barns 
immunsystem idag inte exponeras för tillräckligt mycket mikroorganismer. 
Därmed får immuncellerna inte heller tillräcklig stimulans för att utbildas och 
mogna på ett korrekt sätt. Istället börjar dessa celler överreagera vid kontakt 
med helt ofarliga ämnen, som t.ex. födoämnen, pollen och kvalster, vilket kan 
utlösa allergiska reaktioner. Men trots att hygienhypotesen lanserades för 
snart 30 år sedan vet man ännu inte hur immunsystemets mognad är 
relaterat till allergiutveckling hos barn.   
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För att få svar på detta startades den så kallade BONDGÅRDSFLORA-
studien år 2005. I studien inkluderades 65 barn från Västra Götalands-
regionen. Ungefär hälften av barnen bodde på små mjölkgårdar och hälften 
bodde i samma geografiska område men inte på gårdar. Sedan starten har 
barnen följts med regelbundna blodprovstagningar för immunologiska 
analyser samt med läkarundersökningar för att påvisa eventuell allergi-
utveckling. I arbete I och IV i denna avhandling har vi undersökt 
kopplingar mellan uppväxt-miljö, mognadsgrad av barnens immunsystem 
och risken att utveckla allergi. Barnen på bondgård hade lägre förekomst av 
allergi och en högre mognads-grad av T- och B-celler i blodet jämfört med 
övriga barn. I hela gruppen av barn fann vi dessutom att de som var 
allergiska vid 8 års ålder generellt sett hade en lägre mognadsgrad av sina T- 
och B-celler i blodet under uppväxten än de övriga barnen. Sammantaget 
fann vi att immunsystemets mognad hos det lilla barnet är relaterat till 
allergiutveckling senare i barndomen, vilket kan vara en viktig pusselbit för 
att kunna utveckla strategier för att förhindra allergiutveckling hos barn.  
Efter att immunförsvaret har lärt sig att känna igen sjukdomsorsakande 
mikroorganismer kan det vid en ny kontakt stoppa dessa tidigt utan att några 
infektionssymtom uppstår. Detta fenomen utnyttjas vid vaccinationer. 
Genom att injicera en liten dos av en försvagad version av den mikro-
organism som man vill skydda sig emot undviks infektionssymtom, men 
immunförsvaret lär sig ändå att känna igen mikroorganismen och producerar 
i de flesta fall skyddande antikroppar. Antikroppsnivåerna i blodet efter 
vaccinering varierar kraftigt mellan olika individer och i olika länder, men de 
underliggande orsakerna bakom denna variation är fortfarande okänd. I 
arbete II och III, som också är baserade på BONDGÅRDSFLORA-
studien, har vi undersökt om mognaden av immunsystemet avgör hur 
effektivt barnens immunceller svarar med antikroppsproduktion vid 
vaccinering. Vi fann att nivåerna av de vaccinspecifika antikropparna i blodet 
var starkt sammankopplat med hur moget deras immunsystem var vid 
vaccinationstillfället. Intressant nog tyder våra resultat på att ett mer moget 
immunsystem gynnade svaret mot vissa typer av vaccin (inaktiverade) medan 
det missgynnade svaret mot andra (levande försvagade). Våra resultat 
understryker vikten av att studera samband mellan immunsystemets 
utveckling och vaccinationssvar hos barn. En bättre förståelse av detta 
samband kan vara grunden till att kunna förbättra vaccinationsstrategier i 
olika delar av världen och för att utveckla ännu mer effektiva vacciner än vad 
som finns idag.   
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ABBREVIATIONS	
 
APC Antigen-presenting cell 
BAFF  B cell activating factor  
DAMP Damage-associated molecular pattern 
DTP-vaccine Vaccine against diphtheria, tetanus and pertussis   
GALT Gut-associated lymphoid tissue  
IFN Interferon  
IL Interleukin 
LPS Lipopolysaccharide  
MMR-vaccine Vaccine against measles, mumps and rubella  
NLR NOD-like receptor  
PAMP Pathogen-associated molecular pattern 
PBMCs Peripheral blood mononuclear cells 
PRR Pathogen recognition receptor 
TFH cell  T follicular helper cell 
TFR cell T follicular regulatory cells   
TH cell T helper cell 
TLR Toll-like receptors  
Tregs Regulatory T cells  
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1 THE	IMMUNE	SYSTEM	–	AN	OVERVIEW	
Our immune system has evolved to protect us from harmful pathogens.  
However, while keeping up an effective defense against pathogenic intruders, 
the immune system must also avoid aggressive immune responses to harmless 
antigens in the environment as well as to structures of our own body.  
The immune system consists of several different cell types, which all act in 
concert to direct and tune the immune responses. The innate immune 
system represents our first line of defense and is responsible for rapid 
recognition and eradication of intruding pathogens, but also for clearance of 
dead cells and initiation of repair of damaged tissue. If the pathogen is not 
rapidly cleared by the innate immune system, our second line of defense, i.e. 
the adaptive immune system, will get involved. The key mediators of 
adaptive immunity are the lymphocytes, i.e. T cells and B cells. Unlike cells of 
the innate immune system, lymphocytes are equipped with antigen-
specific receptors.  
T cells are responsible for cell-mediated immunity and their T cell 
receptors recognize peptides from protein antigens presented on MHC 
class I (MHC-I) and MHC class II (MHC-II) molecules. MHC-I molecules 
are present on the surface of all nucleated cells in the body and MHC-II 
molecules are mainly present on antigen-presenting cells (APCs), such as 
dendritic cells, macrophages and B cells. B cells recognize antigens of many 
diverse structures through their B cell receptors, which are surface-bound 
forms of antibodies. Activation of B cells leads to secretion of antibodies 
with the same antigen-specificity as their surface receptor that recognized the 
antigen. Unlike the innate immune system that provide immediate protection 
against intruding pathogens, the adaptive arm of the immune system requires 
expansion and differentiation of antigen-specific lymphocytes before it 
can provide an effective defense. However, once activated, the adaptive 
immune system targets the pathogen with much greater precision and it also 
provides us with immunological memory.  
Anna Strömbeck 
4 
 
2 THE	INNATE	IMMUNE	SYSTEM	
Most pathogens enter the body through the skin and mucosal surfaces, such 
as the gastrointestinal and the respiratory tract. The epithelial lining of 
these surfaces are included as an important component of the innate immune 
system since they form a mechanical barrier against pathogens and also 
produce antibacterial substances, and thus literally constitute our first line of 
defense against intruding pathogens. However, if pathogens succeed in 
crossing the epithelial barrier, the invaders are in most cases rapidly 
recognized by tissue resident phagocytic innate immune cells, such as 
macrophages and dendritic cells. Upon pathogen-recognition, these 
cells become activated and react by secreting a range of cytokines and 
chemokines that act as alarm signals to induce local inflammation. In 
response to proinflammatory cytokines, surrounding blood vessels dilate and 
endothelial cells becomes activated and upregulate adhesion molecules. In 
combination with secreted chemokines, these changes drastically increase the 
entry of circulating innate immune cells, such as neutrophils, natural 
killer cells and monocytes, and also plasma proteins from the 
complement system to the infected tissue, which further promote 
inflammatory responses and eradication of the pathogens.  
Dendritic cells play a pivotal role in the orchestration of immune responses by 
linking innate and adaptive immunity through antigen presentation to T 
cells. Dendritic cells capture antigens and internalize them through 
phagocytosis or receptor-mediated endocytosis. Upon antigen encounter in 
this inflammatory microenvironment, dendritic cells become activated and 
upregulate specific surface co-receptors that are necessary for full activation 
of T cells. In addition, the activated dendritic cells also upregulate the homing 
receptor CCR7, which enables them to migrate into draining lymph nodes, 
where induction of adaptive immune responses occur (see section 3.2).  
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 Danger	recognition	by	innate	immune	cells	2.1
Cells of the innate immune system express several different classes of 
receptors that trigger danger signal dependent activation. Collectively, these 
receptors are referred to as pattern recognition receptors (PRRs), which 
allow the cells to recognize and respond to pathogen-associated structures 
(pathogen-associated molecular patterns, PAMPs) and to danger signals 
released from damaged or necrotic hosts cells (damage-associated molecular 
patterns, DAMPs). Engagement of specific PRRs trigger different signaling 
pathways, which lead to innate immune responses that are tailored for 
eradication of the particular type of microbe encountered. Two major 
receptor families included in PRRs are the Toll-like receptors (TLRs) and the 
NOD-like receptors (NLRs). Humans express 10 functional members of 
the TLR family, i.e. TLR1 to TLR10, distributed on various innate immune 
cells, and each member specifically recognizes one or more PAMP. TLRs 
that recognize molecular components on the surface of pathogens are located 
on the cell surface, whereas TLRs that recognize pathogenic nucleic acids are 
found in the membranes of endosomes where ingested microbes are digested 
[1]. Engagement of TLRs leads to activation of the transcription factors 
nuclear factor-κβ (NF-κβ) and interferon-regulatory factors, which induce 
production of pro-inflammatory cytokines and type I interferons (IFNs), 
respectively. The NLRs are a large family of cytosolic receptors, including 
NOD-receptors and NLRP receptors, which sense PAMPs and DAMPs in 
the cytoplasm. NOD-1 and 2 are specific for bacterial peptidoglycans and, 
similarly to TLRs, activation of these receptors leads to induction of NF-κβ 
and subsequent inflammatory responses. NLRP3 is an important sensor for 
cellular stress. Upon activation, NLPR3 oligomerizes to form a complex, 
known as the inflammasome, which generates IL-1 secretion that induces 
acute inflammation and fever.   
 The	concept	of	‘trained	immunity’	2.2
The established view of immunological memory to be confined exclusively to 
the adaptive immune system has recently been challenged through the 
concept of ‘trained immunity’, which suggest that also cells of the innate 
immune system, such as macrophages and NK cells, develop memory-like 
responses [2]. In this model, innate immune activation by pathogens through 
various PRRs leads to epigenetic modifications, which preserves a 
heightened activation state in the cells for weeks or months. Upon 
Anna Strömbeck 
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subsequent pathogen encounters, the ‘trained’ cells show an improved 
responsiveness with increased production of inflammatory mediators and an 
enhanced capacity to eliminate infection [2]. The increased innate 
responsiveness conferred by trained innate immunity is not pathogen-
specific, and increased responses may be mediated through re-stimulation 
of both the same and different PRRs.  
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3 CD4+	T	CELLS	
 Development	and	selection	of	T	cells	3.1
T cells arise from hematopoetic stem cells in the bone marrow. T cell 
precursors migrate from the bone marrow to the thymus, where they undergo 
several quality control checkpoints and develop into either CD4+ or CD8+ T 
cells. Developing T cells in the thymus are referred to as thymocytes. The T 
cell receptor complex consists of an α-chain, a β-chain, as well as a CD3 co-
receptor. Each α and ß-chain contains one constant region as well as one 
variable region, of which the latter recognize and bind to the antigen. During 
the development in the thymus, the gene segments coding for the α and ß-
chain will undergo random somatic recombination, which will dramatically 
increase the diversity of the receptors expressed by the T cell compartment. 
The most immature T cell precursors in the thymus do not express any of the 
proteins required for the T cell receptor complex, and since they also lack the 
expression of CD4 and CD8, they are referred to as double-negative 
thymocytes. In the next step of development, the thymocytes express both 
CD4 and CD8, as well as low levels of the complete T cell receptor and are 
therefore called double-positive thymocytes. These cells interact with 
thymic epithelial cells that express MHC-I and MHC-II. Thymic epithelial 
cells also express the transcription factor AIRE, which enable expression of 
proteins that are normally only present in peripheral tissues. Thus, thymic 
epithelial cells have the capacity to present a wide range of self-proteins to the 
thymocytes, which is an important part of the quality control of the 
developing T cells.   
Thymocytes that recognize self-peptides on a MHC-molecule with low or 
moderate affinity are positively selected to survive and thereby increase 
the expression of their T cell receptor, whereas T cells that do not recognize 
MHC-molecules in the thymus are considered as useless and die by apoptosis. 
Thymocytes with T cell receptors that recognize peptides bound to MHC-I 
molecules downregulate their expression of CD4, while recognition of 
Anna Strömbeck 
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peptide:MHC-II complexes induces downregulation of CD8. This process 
thus leads to generation of single-positive CD8+ or CD4+ T cells.  
Thymocytes that recognize the self-peptide:MHC-complex with a high 
affinity are negatively selected to undergo apoptosis. This negative 
selection serves to eliminate self-reactive T cells and is a major mechanism 
of central tolerance. However, some of the thymocytes that bind to self-
peptide:MHC-complex with high affinity do not undergo apoptosis, but 
instead develop into CD4+ regulatory T cells (Tregs) that migrate to 
peripheral tissues. Why some of the self-reactive thymocytes die while others 
develop into Tregs is not yet known. The process of negative selection is, 
however, imperfect and some self-reactive T cells also egress into the 
periphery; the ability to induce tolerance also in the periphery thus serves as 
an important back-up system to prevent autoimmunity by these escaping self-
reactive T cells. Peripheral tolerance is also crucial to prevent T cell 
responses to self-peptides that are not presented in the thymus as well as to 
harmless environmental allergens, as described further in chapter 9. It is 
estimated that around 98% of all thymocytes that develop in the thymus also 
die in the thymus, which reflects the intensive quality control the cells 
undergo for the ability to recognize self-peptide:MHC complexes and for self-
tolerance. 
 T	cell	activation	3.2
After maturation into CD4+ T cells in the thymus, naïve T cells, which 
express the RA isoform of the CD45 molecule (CD45RA+), enter the 
circulation. The migration of CD45RA+ T cells between the circulation and 
peripheral lymphoid organs depends on interactions between the 
lymphocytes and tissue-specific chemokines in combination with endothelial 
adhesion molecules. Naïve CD45RA+ T cells express the homing receptor L-
selectin (CD62L) and the chemokine receptor CCR7, which enable migration 
into secondary lymphoid organs, such as lymph nodes, where they may 
become activated by APCs [3, 4].  
When naïve CD4+ T cells enter the lymph node, they migrate to the T cell 
zone in the paracortex to search for their cognate antigen peptides presented 
by APCs. Lymph nodes are highly organized organs that provide a structure 
that is optimized to facilitate T cell interaction with APCs. If the T cell 
receptor and the co-receptor CD4 together identify peptide antigens 
Anna Strömbeck 
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presented on MHC-II molecules on APCs, the T cell initiates its activation 
program. For a full activation to occur, the T cells need to receive co-
stimulatory signals from APCs, such as interactions of CD28 and CD40 
ligand on T cells with CD80, CD86 and CD40, respectively, on activated 
APCs (figure 1). In addition, adhesion molecules on T cells recognize their 
ligands on APCs, which enables the T cell receptor and peptide-MHC 
complex to engage for a sufficiently long period for an activating signal to be 
transmitted into the T cell (e.g. LFA-1 on T cells and ICAM on APCs) [5]. 
Antigen-recognition without adequate co-stimulation results in T cell anergy, 
i.e. unresponsive T cells, or death by apoptosis.  
Upon activation, the antigen-specific CD4+ T cells rapidly start to secrete 
cytokines, such as IL-2. Activated T cells upregulate their expression of high-
affinity IL-2 receptors (CD25), thus enhancing the ability of the T cell to bind 
and respond to IL-2. This autocrine signaling stimulates survival and 
proliferation of the T cell, resulting in a robust expansion of antigen-
specific clones. These newly activated T cells then differentiate into either 
effector T cells or memory T cells.  
 
Figure 1. Activation of a naïve CD4+ T cell by an antigen-presenting cell 
(APC). Activation of naïve CD4+ T cells requires T cell receptor (TCR) recognition 
of a peptide-antigen presented on MHC-II on APCs in combination with co-
stimulatory receptors signaling and stimulatory cytokines.  
 
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 Effector	CD4+	T	cells	3.3
Following activation, the T cells are instructed by the APC and the 
surrounding cytokine milieu to differentiate into functionally distinct effector 
subsets, which are distinguished on the basis of the specific cytokines they 
produce and which transcription factors they express. The classical subsets of 
CD4+ effector T cells include T helper (TH) 1, TH2, TH17, T follicular helper 
(TFH) cells, as well as peripherally induced Tregs (figure 2). Although the 
functional specialization of these effector cell subsets is coordinated by distinct 
genetic programs, there appear to be a certain degree of cellular plasticity and 
flexibility between these programs [6].   
TH1 cells play a critical role in the defense against intracellular pathogens 
and produce cytokines, such as IFN-γ, IL-2 and TNF. IFN-γ is a potent 
activator of macrophages and trigger these cells to enhance their ability to kill 
phagocytosed microbes. Differentiation into TH1 cells is primarily stimulated 
by IL-12, produced by macrophages and dendritic cells, but also by 
monocytes, neutrophils, and B cells [7]. TH1 differentiation can also be 
induced by other cytokines, such as IFN-γ from macrophages, dendritic cells 
and NK cells. These cytokines activate the transcription factors STAT4, 
STAT1 and T-bet [8].  
In contrast to TH1 cells, TH2 cells mediate immune responses to 
extracellular parasites through the production of IL-4, IL-5 and IL-13. 
Differentiation into TH2 cells is driven by IL-4, which may be produced by 
many cell types, such as mast cells, basophils, and by the TH2 cells 
themselves. IL-4 activates the transcription factors STAT6 and GATA-3 [8]. 
In some individuals, TH2 responses are induced in allergic reactions to 
innocuous environmental allergens, as further described in chapter 9.  
TH17 cells mediate responses against fungi and extracellular bacteria, but 
are also associated with autoimmune diseases and chronic inflammation. As 
implied by the name, TH17 cells produce IL-17. This cytokine stimulates 
chemokine production by other cells, which in turn induces inflammation by 
recruitment of neutrophils and monocytes. TH17 cells also produce IL-22, 
which helps to maintain the epithelial barrier functions and promotes repair 
of damaged tissues. TH17 development is promoted by TGF-β, IL-6 and IL-1 
and is dependent on the transcription factor RORC [9, 10]. Stimulation with 
TGF-β alone, however, promote naïve CD4+ T cells to differentiate into 
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Figure 2. Development of effector T cells. Differentiation of naïve            
CD4+ T cells into the classical effector T cell subsets and the cytokines and 
transcription factors involved in the process, as well as the different T effector 
signature cytokines  
 
FOXP3+ Tregs. These peripherally induced Tregs will be further described 
in section 3.5.  
Most differentiated effector T cells leave the lymphoid organs where they 
were activated and migrate to the site of infection/inflammation. Upon re-
encounter with their cognate antigen, the effector cells respond in ways that 
serve to eradicate the pathogen. TFH cells, however, remain in the lymphoid 
organs and migrate into lymphoid follicles where they stimulate the stepwise 
activation of antigen-specific B cells [11, 12]. It was recently demonstrated 
that not only the B cells, but also the TFH cells undergo progressive activation 
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during this interaction, and that these changes are critical for the concurrent 
B cell response [12]. TFH cells are induced by the cytokines IL-21 and IL-17 
and they produce IL-4, IFN-γ and IL-21. The interaction between TFH cells 
and B cells in the lymphoid follicles will be further described in section 4.3. 
Effector T cells are short-lived and die as the pathogen is eliminated, but 
long-lived memory cells of the same subset and specificity are formed, which 
are ready to be activated upon re-encounter with the same antigen.  
 Memory	T	cells	3.4
The acquisition of long-lived antigen-experienced memory T cells may 
provide life-long protection against a pathogen. Memory T cells are 
functionally inactive, but may be rapidly induced to produce cytokines upon 
a secondary encounter with the antigen that once induced their development. 
Activation of memory T cells require much less costimulatory signals than 
activation of naïve T cells. In humans, these cells can be distinguished by the 
expression of CD45RO, as the longer CD45RA molecule is spliced during 
activation of the naïve T cell [13]. Human blood comprise three major sub-
populations of CD4+CD45RO+ memory T cells; central memory T cells 
and stem cell memory T cells, which circulate and migrate to lymphoid 
tissues, and effector memory T cells that have the capacity to traffic to 
mucosal and other peripheral tissues [14]. In addition, non-circulating tissue 
resident memory T cells predominate in mucosal and peripheral tissues 
[14, 15].  
 Regulatory	T	cells	3.5
In contrast to CD4+ effector T cell subsets that promote pro-inflammatory 
responses, Tregs are specialized in suppressing immune responses 
toward self- and environmental antigens [16, 17]. Tregs do not only suppress 
the development and functions of other T cells, but also suppress the 
functions of B cells and innate immune cells such as macrophages and 
dendritic cells. During the development in the thymus, T cells that have a T 
cell receptor with high affinity to self-peptides are induced to develop into 
Tregs through the mechanism of central tolerance, as described in section 3.1 
[18]. In addition to the thymic development of Tregs, antigen stimulation of 
naïve CD4+ T cells in the periphery can also induce Treg differentiation; in 
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vitro, this conversion is triggered by antigen-stimulation in the presence of 
TGF-β [17, 19]. A subset of Tregs, called follicular Tregs (TFR cells) migrate 
to the B cell follicle in peripheral lymphoid organs and induce suppression of 
the TFH cells. This leads to inhibition of the reaction by which B cells develop 
into antibody-producing plasma cells [20]. 
3.5.1 Characterization	of	Tregs	
Tregs specifically express FOXP3, a transcription factor essential for their 
development and function [16, 17]. In mice, forced FOXP3 expression 
converts naïve CD4+ T cells towards a T cell phenotype functionally similar 
to naturally occurring Tregs [21, 22]. Children born with loss of function-
mutations in the FOXP3 gene develop IPEX syndrome (immune 
dysregulation polyendocrinopathy enteropathy X-linked syndrome), which is 
a fatal disorder that often presents in the first year of life. Characteristic 
symptoms of IPEX syndrome includes severe enteropathy, thyroid 
abnormalities, early onset of type 1 diabetes, eczema, food allergy, hyper-IgE 
as well as autoimmune hematologic disorders [23-25].  
FOXP3+ Tregs are found within the CD4+CD25+ T cell population. The 
fraction of FOXP3+ Tregs is highest within the CD25high subset, which 
constitutes approximately the top 2% of the total CD25+ T cell subset [26, 
27]. Since not only Tregs, but also newly activated CD4+ T cells express 
CD25 and FOXP3 [28], analysis of the FOXP3+CD25high T cell subsets 
results in a lower contamination of the Tregs by activated non-regulatory T 
cells [29]. More recently, it been shown that human Tregs express little or no 
IL-7 receptor (CD127); and expression of CD127 in combination with CD25 
can therefore distinguish between human regulatory T cells and conventional 
T cells [30, 31]. Indeed, the proportion of CD25+CD127low T cells correlate 
strongly with the proportion of CD25+FOXP3+ Tregs [30]. Since CD127, 
unlike FOXP3, is expressed on the cell surface, this allows identification of 
viable Tregs for functional studies. Figure 3 shows examples of different 
gating strategies for Tregs.  
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Figure 3. Selected examples of gating strategies for regulatory T cells 
(Tregs). A) Identification of proportions of FOXP3+ cells that are CD25high or CD25+ 
within the CD4+ T cell population. The FOXP3 gate is set based on lack of 
expression within the CD25neg subset. B) Identification of proportions of 
CD25+CD127lo/neg Tregs within the CD4+ T cell population and proportions of 
FOXP3+ cells among Tregs and non-Tregs (adapted from paper IV in this thesis). 
 
Similar to conventional CD4+ T cells, naïve human Tregs express the RA 
isoform of CD45, whereas activated/memory cells express CD45RO [32, 
33]. Recent work in mouse models have identified long-lived antigen-specific 
Tregs with potent immunosuppressive capacities after antigen elimination, 
i.e. memory Tregs [34, 35], and there is now emerging evidence for memory 
Tregs also in humans [35]. 
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3.5.2 Treg-mediated	suppression	
Several mechanisms of Treg-mediated suppression have been proposed, and 
these include both contact-dependent mechanisms and secretion of 
immunosuppressive cytokines, such as IL-10 and TGF-β. In adults, FOXP3+ 
Tregs constitutively express high quantities of CTLA-4, which is essential for 
Tregs to regulate activation and proliferation of other T cells [32, 36, 37]. 
CTLA-4 binds to its ligand CD80/CD86 on APCs with a higher affinity than 
the co-stimulatory molecule CD28 on CD4+ T cells. A blockade of 
CD80/CD86 will make the APCs incapable of providing co-stimulation via 
CD28, which is crucial for T-cell activation [38, 39]. CTLA-4 may also 
downregulate CD80 and/or CD86 on APCs by binding and removing these 
ligands by transendocytosis [40]. As mentioned above, Tregs express high 
levels of CD25, which is a component of the receptor for the essential T cell 
growth factor IL-2. Consequently, Tregs may bind and consume large 
amounts of IL-2, thus reducing its availability for other T cells.  
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As mentioned in chapter 1, B cells are 
key players in the humoral immune 
response, and they mediate their 
main function through antigen-
specific antibodies. Similarly to T 
cells, B cells develop in the bone 
marrow from hematopoetic stem 
cells. When immature B cells leave 
the bone marrow and enter the blood 
stream and peripheral lymphoid 
organs, they undergo several 
transitional developmental stages 
before they are fully mature. These 
stages are defined based on 
expression of different cell surface 
antigens, and the current model 
involves five major consecutive 
stages: immature transitional B cells 
that have just left the bone marrow, 
mature naïve B cells that have not yet 
encountered antigen, actively 
engaged germinal center B cells, 
memory B cells and antibody-
secreting plasma cells [41] 
(figure 4).  
  
Figure 4. Peripheral B cell maturation. 
Immature transitional B cell  
Mature naïve B cell  
Germinal center B cell  
Memory B cell 
  
Plasma cell 
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 T	cell	mediated	activation	of	B	cells	4.2
B cells leave the bone marrow and enter the circulation as CD24hiCD38hi 
immature transitional B cells [42]. The expression of CD24 and CD38 
gradually decrease as the B cells develop from the immature transitional stage 
toward a more mature naïve phenotype, and based on this, human 
transitional B cells can be further subdivided into T1, T2 and T3 B cells, T1 
being the most immature [43]. These B cells constantly recirculate between 
the blood and peripheral lymphoid organs, i.e. lymph nodes, the spleen and 
mucosal lymphoid tissues. B cell activating factor (BAFF) is a cytokine 
produced by both innate immune cells and non-hematopoietic cells, such as 
lymph node stromal cells [44-46], and BAFF has been shown to be pivotal for 
differentiation of immature transitional cells into mature naïve B cells [47, 
48].  
When B cells enter a lymph node, they migrate into follicles (B cell zone), 
located in the cortex of the lymph node. Mature naïve CD24intCD38int B 
cells that recognize their specific antigen through their B cell receptor will 
internalize and process the antigen and then present the peptides on surface 
MHC-II molecules. Antigen-activated B cells transiently increase their 
expression of CCR7 and migrate to the border of the B cell follicle and the T 
cell zone. At this location, the B cells may interact with CD4+ TH cells that 
recognize the cognate antigen and receive additional signals, e.g. from 
binding of CD40 to CD40 ligand, which leads to proliferative expansion of 
the antigen-specific B cells. In T cell dependent B cell responses, the 
antigen-activated B cell can subsequently follow three different pathways 
[49]:  
1. differentiation into extrafollicular short-lived plasma cells that 
typically secretes low levels of antibodies with low affinity 
2. differentiation into germinal center-independent memory B 
cells, 
3. or formation of germinal centers that result in the generation 
of affinity-mature memory B cells and long-lived plasma cells. 
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 The	germinal	center	reaction	4.3
During the germinal center reaction, the rapidly proliferating B cells acquire 
random mutations in the antigen-binding region of the B cell receptor to 
enhance the affinity for the antigen, i.e. somatic hypermutations. The 
affinity-matured B cells may then relocate to the light zone of the germinal 
center where affinity selection takes place through interaction with antigen-
presenting follicular dendritic cells and antigen-specific TFH cells. B cells with 
disadvantageous mutations will undergo apoptosis, while cells that obtained a 
higher affinity will survive and undergo isotype class switch of the 
constant region from IgM to IgG, IgE or IgA, which alter the effector 
function of the antibody. After class switch, the B cells may differentiate into 
either germinal center-dependent memory B cells or into plasmablasts that 
subsequently mature into long-lived antibody producing plasma cells, 
as also mentioned in section 4.2.  
 Plasma	cells 4.4
After the germinal center reaction, the plasmablasts tend to migrate to the 
bone marrow or mucosal tissues where they mature into long-lived plasma 
cells, which produce high-affinity antibodies that may clear the primary 
pathogen. Plasma cells beneath mucosal surfaces, e.g. in the gut and 
respiratory organs, produce IgA antibodies that are transported across the 
epithelia into the lumen of the organ, where it may bind to and neutralize 
microbes. Plasma cells do not express a surface-bound antigen receptor, but 
instead release high-affinity antibodies at a constant rate also in the absence 
of the antigen [50]. Preexisting circulating antibodies function as an 
immediate protection upon re-encounter with the specific pathogen. Specific 
serum antibody titers can have half-life in the range of 50-200 years [51]. 
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 Memory	B	cells		4.5
As mentioned above, a fraction of the B cells that have gone through the 
germinal center reaction develop into isotype-switched memory cells with 
high affinity for the previous encountered antigen. These cells circulate in the 
blood and reside in mucosal and other tissues and may survive for extended 
periods of time, even in the absence of antigen exposure. Indeed, vaccine-
specific memory B cells have been detected more than 50 years after smallpox 
vaccination in humans [52]. In contrast to plasma cells, memory cells express 
surface bound antigen receptors, and antigen recognition is necessary to 
trigger a memory response. Upon a re-infection, memory B cells rapidly 
differentiate into plasmablasts that produce large amounts of high-affinity 
class-switched antibodies capable of clearing the pathogen [49]. Essentially all 
B cells that have undergone class switch and somatic hypermutations express 
CD27, which has consequently been considered as a general marker for 
memory B cells in humans [53]. Memory B cells can also be distinguished by 
the CD24highCD38neg phenotype, and most of these cells do express CD27 
[54].  
In addition to isotype-switched memory B cells, the existence of IgM 
memory B cells, also called natural memory B cells, have been described 
[55, 56]. IgM memory B cells are suggested to develop in the spleen upon 
TLR-stimulation in a T cell independent manner and in the absence of 
germinal centers [56]. As the name implies, IgM memory cells are non-
switched and they produce antibodies of the IgM isotype with fewer somatic 
mutations as compared to switched memory B cells [56]. It has been 
suggested that IgM memory B cells are key players in T cell independent 
immune responses and that lack of these cells are associated with an inability 
to respond to polysaccharide antigens and increased susceptibility to certain 
bacterial infections [57].   
Thus, the immune system can memorize previously encountered antigens by 
continued production of antigen-specific antibodies and by memory B- and T 
cells. These capabilities are fundamental for successful vaccinations, which 
will be further described in chapter 7. 
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5 ADAPTIVE	IMMUNITY	COMES	WITH	AGE	
Most of the global mortality in children under 5 years of age is caused by 
infections, and the highest mortality rate is found among newborns and 
infants. This vulnerability slowly decreases as the immune system gradually 
matures during infancy and childhood, after encounter with an increasing 
number of pathogens. Due to the low exposure to external antigens in utero, 
the adaptive immune system in newborns is mainly composed of naïve T and 
B cells. Since these naïve cells require at least 1-2 weeks after antigen 
encounter to provide effective immune responses, the newborn baby has to 
rely on the innate immune system to provide protection. However, during 
this critical period in life the baby is also provided with protective maternal 
IgG antibodies transferred to the baby during pregnancy and also with 
maternal IgA if the baby is breastfed (described further in section 5.2). 
 
However, although designated the name “innate”, numerous components of 
this arm of the immune system are also characterized by immaturity and 
impaired function in neonates as compared to adults [58]. For instance, 
dendritic cells from newborns express lower levels of MHC-II as well as of the 
co-stimulatory receptors CD80, CD86 and CD40 as compared to adults [59, 
60], and neonatal neutrophils show impaired functions, such as a reduced 
ability to migrate from the circulation to sites of infection [61]. Furthermore, 
although the expression of TLRs on innate cells in early childhood appear to 
be comparable to adult levels, stimulation of TLRs and the 
inflammasome/IL-1 pathway fail to induce potent proinflammatory 
responses [62, 63]. Thus, not only the adaptive but also the innate immune 
system seems to be impaired at birth, which makes the newborn extra 
vulnerable to infections.  
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 Peripheral	T	cell	maturation	in	children	5.1
At birth, naïve CD45RA+ T cells constitute approximately 90% of all 
circulating CD4+ T cells [64, 65]. However, as children grow older and 
encounter new antigens, the proportion of naïve T cells declines while 
proportions of CD45RO+ memory T cells increase. The fraction of 
CD45RA+ T cells drops significantly already in the first month of life, and at 
three years of age these cells constitute around 70% of all CD4+ T cells in the 
circulation [64, 65]. The proportions of CD45RA+ T cells continue to 
decrease throughout childhood, adolescence and adulthood, and at 90 years 
of age only around 20% of all circulating CD4+ T cells are of a CD45RA+ T 
cell phenotype [66].  
In accordance, the proportions of CD45RO+ memory T cells in peripheral 
blood increase gradually from approximately 5% of all peripheral T cells at 
birth to just below 20% at three years of age [14, 64, 66]. At the age of three, 
there is a large individual variation in the proportions of these cells, ranging 
from 10% up to almost 40%, which might reflect differences in antigen 
exposure between children [64, 66]. The proportion of circulating memory T 
cells continues to increase gradually with age, and constitutes around 80% of 
all CD4+ T cells at 90 years of age [66]. Consistent with memory T cells in 
blood, the proportions of memory T cells in peripheral tissues, including 
lymphoid tissues, gut, lungs, and skin, also increase with age [14, 15]. The 
adaptive immune maturation progress in childhood is accompanied by an 
enhanced capacity to produce cytokines. For instance, the production of 
TNF, IFN-γ, IL-4, IL-5 and IL-10 upon polyclonal stimulation of blood cells 
increases in the first year of life [67, 68]; and the capacity to produce IFN-γ, 
IL-4 and IL-5 has been shown to continue to increase in an age-dependent 
manner at least until adolescence [69].  
It is well known that T cells express a broad homing receptor repertoire. 
The expression of certain homing receptors differ based on the activation 
status of the T cells. For example, naïve CD4+ T cells express the homing 
receptor CD62L and CCR7, which enable migration into secondary 
lymphoid organs, as also mentioned in section 3.2. Upon activation, these 
homing receptors are downregulated and the T cell acquires new homing 
receptors, which direct the cell to the target tissue where its effector functions 
are needed [3, 4]. Thus, T cells activated in lymph nodes draining the skin or 
the lung start to express the homing receptor CCR4, while T cells activated 
in the small intestine start to express CCR9 [70-72]. Naïve T cells also 
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express the homing receptor α4β7, which interacts with the adhesion 
molecule MAdCAM-1. In adults, MAdCAM-1 is expressed primarily in the 
gut-associated lymphoid tissue (GALT), but also in the lactating mammary 
gland [73, 74]. However, during fetal development and early childhood 
MAdCAM-1 is also expressed in peripheral lymph nodes [75]. In our 
prospective birth cohort study, we have previously shown that CD4+ T cells 
undergo a homing receptor switch, from being α4β7+ to CCR4+ in parallel 
with their differentiation from a naïve CD45RA+ to an activated/memory 
CD45RO+ T cell phenotype [26]. Indeed, the proportion of α4β7+ cells of 
CD4+ T cells decrease from around 90% in cord blood to 70% at three years 
of age, similar to the proportions of CD45RA+ T cells, while the proportions 
of CCR4+ T cells increase [64]. Is thus seems like the expression of α4β7 may 
be used as a differentiation marker for CD4+ T cells [26].  
5.1.1 Regulatory	T	cells	in	children	
Similar to conventional CD4+ T cells, naïve human Tregs express CD45RA 
whereas activated cells express CD45RO [32, 33]. The highest fraction of 
CD45RA+ Tregs is found in cord blood and the proportions of these cells 
gradually decline with age, whereas the proportions of CD45RO+ Tregs 
increase [33]. Naïve Tregs also express the homing receptor α4β7, and we 
have previously shown that a homing receptor switch to CCR4 is associated 
with memory conversion of Tregs [26].  
In line with others, we have shown that the proportion of Tregs among 
circulating CD4+ T cells increases rapidly during the first days after birth [33, 
76]. After this rapid increase, the fraction of Tregs remains relatively constant 
throughout childhood and adulthood [33]. Interestingly, the proportions of 
Tregs among CD4+ T cells in cord blood display a remarkably large inter-
individual variation, which is considerably reduced already 3 days after birth 
[76]. Since the variation between children exists already at birth, this suggests 
that proportions of Tregs in neonates are influenced by the environment in 
utero, genetic factors, or a combination of both.  
Interestingly, higher proportions of FOXP3+CD25+ or CTLA-4+ Tregs in 
early infancy have been shown to be associated with lower fractions of 
CD45RO+ memory T cells and CCR4+ T cells later in childhood [64]. Since 
Tregs possess potent immunoregulatory properties already at birth [30, 77], a 
high proportion of these cells in infancy could reduce activation and tissue 
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trafficking of T cells and thus modulate peripheral T cell maturation during 
childhood, which may be an explanation for the observed associations.  
 Peripheral	B	cell	maturation	in	children	5.2
Almost 95% of all circulating B cells in the first months of life are of a naïve 
CD27neg phenotype [78]. Approximately 50% of all B cells in newborn 
children are further characterized as phenotypically immature CD24hiCD38hi 
transitional cells, and the proportion of these cells decrease in an age-
dependent manner until early teenage years, when proportions are 
comparable with those in adults (~5%) [79]. Similarly, after hematopoetic 
stem cell transplantation in adults, immature transitional B cells are the first B 
cells detected in peripheral blood [79], and the proportion of these cells 
gradually decreases with time, while the proportion of mature naïve 
CD24intCD38int B cells increases to around 80% 9 months after 
transplantation [79]. As for memory T cells, memory B cells survive for long 
periods of time in the absence of antigen, and the proportion of these cells 
hence increase with age. The proportions of circulating CD27 expressing 
memory B cells in children are below 5% during the first months in life, 
increase significantly between 4 and 18 months, and then continue to 
increase in an age-dependent fashion to approximately 20% in young adults 
[78, 80]. Figure 5 shows a schematic overview of age-related B cell 
maturation. 
We and others have shown that the vast majority of the circulating 
transitional B cells also express CD5, both in newborns and in adults [54, 79, 
81]. In mice, expression of CD5 identifies a specific B cell lineage, referred to 
as B-1a cells, which are primarily found in the peritoneal cavity [82]. In 
humans however, expression of CD5 does not define a specific B cell subset; 
instead, it likely represents immature naïve B cells. Indeed, CD5 expression 
decreases gradually as the B cells develop from the immature transitional 
stage via mature naïve to memory B cells [43, 54, 79]. We have shown that 
the proportions of circulating CD5+ B cells increase significantly from birth 
(~40%) up to one month of age (~70%); thereafter, the proportions of these 
cells decease in an age-dependent manner, similar to transitional B cells [80, 
83]. Furthermore, approximately 90% of the peripheral CD5+ B cell 
population in both children and adults are of a naïve CD24hi/intCD38hi/int 
phenotype [81].  
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Figure 5. Age-related B cell maturation. Selected examples of phenotypical cell 
surface markers that distinguish different peripheral B cell maturation stages as well 
as their proportional changes in blood with age. 
 
A general immaturity in the early life B cell compartment is also 
accompanied by blunted antibody production as compared with adults. 
However, in parallel with postnatal B cell maturation, the antibody-
producing capacity is enhanced and there is an age-related increase in IgG- 
and IgA-expressing B cells in the circulation [84, 85]. Numerous different 
factors have been suggested to account for impaired neonatal B cell responses 
[86]. For instance, neonatal B cells and dendritic cells have lower surface 
expression of the co-receptors CD40, CD80 and CD86 compared with cells 
from adults [60]. Additionally, neonatal T cells have a lower gene expression 
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of CD40 ligand as compared to adults [60]. Since the interaction between 
CD40 and CD40 ligand along with CD80/86 and CD28 is crucial for T cell 
activation, and the interaction between CD40 and CD40 ligand is central for 
proliferative expansion of antigen-specific B cells, hampered interactions 
between these molecules in neonates most probably contribute to decreased B 
cell responses in neonates. Additionally, a reduced capacity of neonatal TFH 
cell expansion and defective localization of these cells within the lymph nodes 
have been suggested as other key limiting factors for effective B cell responses 
in early life [87].  
To counterbalance these deficiencies in neonatal immunity, maternal IgG 
antibodies pass through the placenta to the blood stream of the baby during 
pregnancy. These passively transferred antibodies will protect the infant 
during the first months of life from infections already experienced by the 
mother. If the baby is breastfed, it will also receive maternal IgA antibodies 
through the breast milk. These antibodies are the product of maternal 
immune responses to pathogens encountered in the gut and in the airways, 
and will be passively transferred to the gut of the infant to provide protection. 
Thus, in addition to transplacental transfer of maternal IgG, a breastfed 
infant will also be provided with local protection against gastrointestinal 
pathogens that are common in the environment where the mother lives [88].  
 Absolute	numbers	of	T	and	B	cells		5.3
The absolute numbers of circulating CD4+ T cells and B cells peak at around 
4 months in life, and thereafter gradually decrease with age [89, 90]. In our 
prospective birth-cohort, we demonstrate that higher total numbers of CD4+ 
T cells during infancy is associated with higher proportions of naïve α4β7+ T 
cells, but with lower proportions of CD45RO+ memory T cells in early 
childhood as well as in school-aged children [89]. Similarly, high numbers of 
B cells in infancy are associated with higher proportions of naïve α4β7+ T 
cells and lower proportions of CD45RO+ memory T cells in childhood [89]. 
Important to emphasize is that these results do not demonstrate any causal 
relationship between low infantile lymphocyte counts and immune 
maturation and activation. Instead, our results indicate that higher total 
numbers of CD4+ T cells and B cells in infancy may reflect a more 
immature/naïve adaptive immune system in general.  
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6 WHAT	MAY	INFLUENCE	ADAPTIVE	
IMMUNE	MATURATION	IN	CHILDREN?	
 Geographical	differences		6.1
It has been demonstrated that cord blood lymphocyte maturation and 
activation status differ notably between babies born in areas with a more 
traditional lifestyle with high microbial exposure, and babies born in areas 
with lower microbial exposure. For example, neonates from a semi-urban 
area in Gabon present with significantly lower proportions of naïve CD5+ B 
cells at birth compared to babies born in an urban area in Austria [91]. In 
addition, the expression of the co-stimulatory molecule CD28 on CD4+ T 
cells is significantly reduced in cord blood from Gabonese children [91]. 
Since CD28 have been shown to be down-regulated on antigen-experienced 
T cells [92], these results suggest that neonates in Gabon have a more mature 
T cell compartment as compared to neonates in Austria.  
The same tendency also applies at older ages, as adolescents and adults from 
rural or semi urban parts of Malawi and Ethiopia, respectively, present with 
significantly higher proportions of antigen-experienced memory CD4+ T cells 
than their age-matched counterparts in the UK and in the Netherlands [93, 
94]. Furthermore, adults from the Netherlands present with higher total 
numbers of circulating CD4+ T cells compared to the Ethiopian group [93]. 
This supports our finding that higher numbers of CD4+ T cells may reflect a 
more naïve/immature adaptive immune system [95]. Interestingly, in a study 
comprising young adults from rural areas of Senegal, urban areas of Senegal, 
and urban areas of the Netherlands, the proportions of memory T and B cells 
show a rural to urban gradient [96]. Thus, young adults from rural areas of 
Senegal presented with highest proportions of both CD45RO+ memory T 
cells and CD27+ memory B cells, while individuals from urban areas of the 
Netherlands presented with the lowest [96].  
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Regarding Tregs, it has been shown that the proportion of circulating CD4+ 
T cells that are CD25hi is significantly lower in cord blood from Gabonese 
compared to Austrian neonates [91]. Also, the expression of FOXP3 and 
CTLA-4 by CD4+CD25hi T cells is significantly lower in cord blood from the 
Gabonese infants [91]. In line with this, cord blood from newborn babies in 
rural areas of Papua New Guinea constitute significantly lower proportions of 
Tregs compared to cord blood from babies in urban parts of Australia [97]. 
The finding that environments with higher microbial exposure seem to be 
associated with lower proportions of blood Tregs in children, will be further 
discussed in section 6.2.2. Although some of the geographical differences 
reviewed above may owe to genetic variability, these results point to that the 
environment, both pre- and postnatally, impacts adaptive immune 
maturation.  
 The	farming	environment	 6.2
The traditional farming environment with many different animal species 
provides an environment with a high microbial antigen diversity that have 
few equals in western affluent countries today. The airborne dust in animal 
sheds contains particles from numerous species of bacteria and molds, which 
are transported into the dwelling house. Indeed, farming environments are 
associated with increased exposure to various microbial products, and 
higher levels of endotoxins, i.e. lipoplysacharide (LPS), and mold β(1,3)-
glucans as well as fungal extracellular polysaccharides have been measured in 
house dust of farming families [98-100]. Interestingly, a recent study shows 
that endotoxin levels in airborne dust were strikingly higher in homes of 
Amish, who practice traditional farming on single-family farms, compared to 
homes of Hutterites, who live on larger and more industrialized farms [101]. 
Thus, since there seem to be a gradient of endotoxin exposure related to 
farming practices, this should be considered when comparing results from 
separate studies investigating associations between farming environment and 
immune maturation.   
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6.2.1 The	farming	environment	and	innate	immunity		
It has been shown that blood cells from farmers’ children have a significantly 
higher spontaneous production of IL-12 and IL-10, and that this production 
correlates with the number of specific farm exposures [102]. Additionally, 
farmers’ children have a significantly higher gene expression of TLR2, TLR4, 
and CD14 in peripheral blood compared to non-farmers’ children at school 
age [103-105]. Both TLR2 and TLR4 are membrane-bound receptors that 
recognize various PAMPs on pathogen surfaces, while CD14 interacts with 
several TLR ligands and enhances their ability to activate TLRs. The authors 
suggest that the difference in expression is related to increased environmental 
exposure to microbial compounds in the farming environment.  
Interestingly, the increased gene expression among farmers’ children was not 
associated with the current exposure of the child, but rather to maternal 
exposure during pregnancy [104]; and upregulation of gene expression in 
farmers’ children increased along with increasing number of farm animal 
species encountered by the mother during pregnancy [104]. Since TLR2 and 
TLR4 are receptors for different types of microbial compounds, the authors 
speculate that the dose-dependent upregulation of these receptors may be due 
to exposure to both increased levels and diversified microbial compounds 
[104]. Thus, maternal exposure to the rich microbial environment of 
traditional farms during pregnancy may induce prenatal immuno-
programming with long-lasting upregulation of innate immunity gene 
expression.  
Long-term exposure to high endotoxin levels may, however, also induce a 
tolerogenic mechanism referred to as LPS-tolerance [106]. This 
phenomenon may explain why school-aged children who were exposed to 
higher levels of endotoxins in childhood have peripheral blood cells with a 
lower capacity to produce TNF, IL-12, and IL-10 in response to LPS-
stimulation in vitro [100]. Similarly, lower LPS-induced TNF production by 
peripheral blood mononuclear cells (PBMCs) among farmers’ children at 4 
years of age has been reported [102]. Also, in the study of school-aged Amish 
and Hutterite children mentioned above, blood cells from Amish children 
produced significantly lower levels of several cytokines after LPS-stimulation 
in vitro, as compared with Hutterites [101]. In addition, Amish children had 
increased proportions of neutrophils and eosinophils, but similar proportions 
of monocytes as compared with Hutterites [101].  
  
Anna Strömbeck 
30 
 
6.2.2 The	farming	environment	and	adaptive	immunity	
The	farming	environment	and	CD4+	T	cells	–	prospective	studies		
Longitudinal data that demonstrate the influence of a farming environment 
on adaptive immune maturation in children have been lacking. To the best of 
our knowledge, we are the first to present detailed prospective data that 
demonstrate how farmers’ and non-farmers’ children from the same rural 
area differ in regard to peripheral T cell maturation throughout childhood. In 
the FARMFLORA birth-cohort study, we demonstrate that growing up in a 
dairy farming environment is associated with lower proportions of Tregs, 
defined as FOXP3+CD25hi of CD4+ T cells, but with a more pronounced T 
cell memory conversion and PBMCs with higher PHA-induced production of 
IFN-γ and IL-1β in the first three years in life [76]. Although these findings 
need to be confirmed in additional larger prospective birth-cohort studies, 
they suggest that growing up in a farming environment is associated with a 
more rapid acquisition of adaptive immunity in childhood. This may partly 
be explained by exposure to higher levels and diversity of microbial 
compounds that trigger innate and adaptive immune responses among 
farmers’ children.  
The	farming	environment	and	CD4+	T	cells	-	cross	sectional	observations		
Few studies have investigated whether proportions of Tregs differ between 
farmers’ and non-farmers’ children and results are conflicting. This 
inconsistency may in part confer to differences in phenotypic characterization 
of Tregs in the studies. A study in rural parts of Germany has shown that 
farmers’ children present with higher proportions of CD4+CD25hi cells of 
total cord blood mononuclear cells compared to non-farmers’ children [107]. 
This observation was not confirmed in our Swedish cohort, where no 
difference in proportions of FOXP3+CD25hi of CD4+ T cells in cord blood 
was observed between farmers and non-farmers children [76]. At three days 
of life, however, farmers’ children in Sweden presented with significantly 
lower proportions of these putative Tregs in the circulation than non-farmers’ 
children [76].  
The Swedish farm children had significantly lower proportions of 
FOXP3+CD25hi of CD4+ T cells also at 3 years of age as compared to non-
farmers’ children [76]. A study from central Europe shows that the 
proportions of Tregs, defined as the upper 20% CD4+CD25+ T cells that 
were FOXP3+ among total lymphocytes, did not differ between farmers’ and 
non-farmers’ children at 4 years of age [108]. However, when they, in the 
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same study, identified Tregs as CD4+CD25hiCD127- of total lymphocytes, 
they found that the proportions of these cells were significantly increased 
among farmers’ children [108]. Since differences in phenotypic 
characterization of Tregs from a single study resulted in dissimilar outcomes, 
this also illustrates difficulties when comparing the outcomes from several 
separate studies. Although significant differences were observed regarding 
endotoxin exposure and innate immunity gene expression between Amish 
and Hutterites, the proportions of Tregs, defined as CD4+FOXP3+CD127-, 
did not differ between these two groups of children [101].  
In addition to differences in phenotypic characterization of Tregs, another 
explanation for discrepancies in results between studies are putative 
differences in farming practices, as reviewed in section 6.2 . In Sweden, cows 
are kept in a barn separated from the dwelling house during the winter 
period. In many of the studies from central Europe, however, the animal 
sheds are generally located closer to the dwelling house, not seldom even in 
the same building. One more important parameter for inconsistent results is, 
of course, the differences in life style between the farming families and the 
control families.  
It has further been shown that mitogen-stimulated blood cells from children 
born by mothers who live on a farm have increased capacity to produce IFN-
γ at birth [109] and at 3 months of age [110], compared to non-farmers’ 
children. In our prospective cohort, a farming environment was associated 
with higher cytokine responses upon mitogen-stimulation of PBMCs at 18 
months of age [76]. In addition, the spontaneous production of IL-10, IL-12 
and IFN-γ by PBMCs is higher among farmers’ children at 4 years of age, 
and this production correlated with the number of specific farm exposures 
[102].  
The	farming	environment	and	B	cells			
Studies investigating longitudinal associations between farming environments 
and peripheral B cell maturation are lacking. However, we demonstrate that 
farmers’ children have significantly higher proportions of memory B cells, 
defined as CD27+ or CD24hiCD38lo/neg, but lower proportions of 
CD24intCD38int mature naïve B cells at 8 years of age, as compared to non-
farmers’ children in the same rural area (Strömbeck et al in manuscript: paper 
IV in this thesis). As mentioned in section 4.1, the cytokine BAFF is crucial 
for differentiation of transitional B cells into mature naïve cells, and we have 
shown that higher BAFF levels at birth are associated with a higher degree of 
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peripheral B cell maturation in the first three years in life [111]. There is a 
striking inter-individual difference in cord blood BAFF levels, which suggests 
that BAFF levels may be influenced by prenatal immuno-programming. 
Indeed, babies born by mothers who live on dairy farms have significantly 
higher BAFF levels in cord blood compared to babies born by non-farming 
mothers [111]. Thus, the increased degree of maturation of the circulating B 
cell compartment in farmers’ children may be initiated already before birth 
by prenatal immunoprogramming due to maternal farm exposure.  
 ! ,+%")'"'+B4?
The gut microbiota may stimulate adaptive immunity in children by several 
means. Lymphocytes are found throughout the intestinal tract, both in 
organized tissues, such as Peyer’s patches and isolated lymphoid follicles, 
and scattered close to the mucosal epithelium and in the underlying lamina 
propria. These organized secondary lymphoid structures in the gut, together 
with the draining mesenteric lymph nodes, comprise the gut associated 
lymphoid tissue (GALT).  
The intestines are generally designed to protect us from entry of harmful 
pathogens. However, GALT has an epithelial structure that facilitates antigen 
entry. Epithelial M cells, localized over Peyer’s patches in the small intestine, 
are specialized for sampling and transepithelial transport of antigens [112]. 
These antigens are then captured by dendritic cells and macrophages within 
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the Peyer’s patches and presented to the lymphocytes [113]. Tissue-resident 
dendritic cells are also able to open tight junctions between adjacent luminal 
epithelial cells and stretch dendrites between the epithelial cells into the 
intestinal lumen to directly take up bacteria [114]. Early in life, bacteria can 
also cross the gut epithelium via a process termed translocation and 
thereby get in contact with the underlying lymphoid tissues and tissue 
resident dendritic cells and macrophages. Later in childhood, however, 
production of secretory IgA antibodies together with a protective mucus 
layer will block translocation. Thus, acquisition of a diverse gut microbiota 
with a broad spectra of bacterial antigens early in infancy, may provide 
important stimuli for the developing immune system in children.  
Numerous experimental studies in various animal species have 
emphasized the importance of bacterial gut colonization for normal 
maturation of the immune system. For example, mice raised under germ-free 
conditions present with fewer and smaller Peyer’s patches with reduced 
numbers of T cells as well as with mesenteric lymph nodes that lack distinct 
germinal centers [115, 116]. Germ-free mice also have lower proportions of 
Tregs within the CD4+ T cell population in the colon lamina propria 
compared to colonized mice [117, 118]. It has also been shown that serum 
antibody levels during the first weeks of life differ significantly between piglets 
that were colonized shortly after birth and piglets that were maintained 
uncolonized [119]. At 2 weeks of age, serum IgM levels were 30-fold higher 
in colonized compared to non-colonized piglets and at 6 weeks, the IgG levels 
were more than 10-fold higher [119]. Thus, it is clear that the gut microbiota 
provides critical stimuli for adaptive immune maturation; however, the 
impact of infantile gut bacterial colonization pattern on long-term adaptive 
immune maturation in children has not yet been established.  
The infantile gut colonization pattern has changed over the last decades in 
Sweden and other affluent countries, possibly due to the parallel 
improvement of sanitary conditions at maternity wards and in the home 
environment [120]. Escherichia coli (E. coli), bifidobacteria and 
Bacteroides are recognized as early gut colonizers in classical studies of the 
infantile gut colonization pattern, and at least the acquisition of E. coli is often 
delayed in modern western societies [120-122]. Instead, early colonization by 
typical skin bacteria, such as Staphylococcus aureus (S. aureus) and other 
staphylococci has become more common in western infants, possibly due to a 
reduced competition from more “traditional” gut colonizers [120].  
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As mentioned above, IgA is an important contributor to gut barrier function, 
and IgA-secreting plasma cells of the gut are predominantly found within the 
lamina propria. Studies of infant gut biopsies show that no plasma cells are 
present in the lamina propria at birth [123, 124], which is yet another 
contributing factor for the enhanced susceptibility to infections among 
newborns. The first plasma cells observed in the infant gut are IgM plasma 
cells, and the first IgA plasma cells appears around 12 days of life [123]. Both 
IgM and IgA plasma cells increase quantitatively during the first weeks of life; 
but IgA plasma cells increase more rapidly and are the  predominant plasma 
cell isotype in infant gut within 3 weeks of life [123]. Thus, plasma cell 
antibody responses in the gut seem to develop along with the establishment of 
the gut microbiota. Interestingly, it has been shown that Pakistani infants 
from poor urban areas have an accelerated maturation of the salivary 
secretory IgA system compared to age-matched Swedish infants [125]. At 2-3 
weeks of age, the Pakistani infants had significantly higher levels of secretory 
IgA against E. coli compared to Swedish infants, and this difference increased 
during the first months of life [125]. Indeed, gut colonization by E. coli starts 
earlier in Pakistani compared to Swedish infants [126]. Similar associations 
were observed in another prospective study where salivary secretory IgA was 
compared between Swedish and Estonian children [127]. According to the 
authors, the accelerated maturation of the salivary IgA system in the Estonian 
children was most probably a consequence of higher microbial pressure in 
their environment [127]. It has further been shown that the number of 
Bifidobacterium species in the infantile gut flora of Swedish children correlate 
with salivary secretory IgA levels during the first year in life [128]. 
By multivariate factor analysis, we have previously shown that infantile gut 
colonization by E. coli and/or bifidobacteria (i.e. presence yes/no in faecal 
cultures) is associated with higher numbers of circulating CD27+ memory B 
cells in children up to up to 18 months of age in our prospective birth-cohort 
study [80]. Early gut colonization by E. coli and bifidobacteria also seems to 
be associated with an enhanced PHA-induced capacity of circulating PBMCs 
to produce cytokines, such as TNF, IL-6, IL-5 and IL-13, at 3 years of age 
(Rabe et al, in manuscript; Appendix A). In our cohort, PHA-induced 
production of IFN-γ was unrelated to the early gut colonization pattern. 
Others have reported that PHA-induced IFN-γ production by PBMCs at 1 
year of age is unrelated to infantile colonization by Bacteroides fragilis [128].  
Although the infantile gut colonization pattern has changed over the last 
decades in Western infants, it is still not known whether these alterations 
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influence child health. Nevertheless, alterations in gut colonization patterns 
have been implicated in the predisposition of several different diseases, such 
as for example allergy (see section 9.5), and the link between acquisition of the 
gut flora and development of allergy is indeed an area of intense research.  
 Delivery	mode	6.4
The rate of children born via cesarean section has increased rapidly both in 
the US and Europe over the last decades [129, 130]. It is known that the 
intestinal microbial colonization pattern differs between infants delivered by 
cesarean section or vaginally. For example, sectio-delivered infants display a 
delayed intestinal colonization by E. coli and Bacteroides and they also have a 
lower intestinal microbial diversity [120, 131]. Surprisingly little is however 
known regarding long-term differences in adaptive immune maturation 
between children born vaginally or by cesarean section.   
When we prospectively investigated associations between delivery mode and 
adaptive immune maturation in childhood, we found that children born by 
cesarean section had significantly higher proportions of circulating Tregs at 
18 months of age, compared with vaginally born children [132]. Multivariate 
analyses further showed that delivery by sectio was associated with higher 
proportions of naïve CD5+ B cells in infancy as well as with higher total 
numbers of T and B cells at 18 months of age. In contrast, vaginal birth was 
associated with higher proportions of CD45RO+ memory T cells and CD27+ 
memory B cells [132]. Even though only 9 out of 55 children were born via 
cesarean section in our birth cohort, these results indicate that delivery by 
sectio is associated with delayed adaptive immunity in early childhood. 
However, no associations between delivery mode and adaptive immune 
maturation were observed when the children had reached school age 
(unpublished results). Our results from early childhood are in accordance 
with a recent prospective study demonstrating that 2-10 year old sectio-
delivered children present with lower proportions of memory T cells 
compared to vaginally born children [133]. Further, during the first two years 
in life, CD4+ T cells from children delivered by cesarean section show a 
decreased proliferative capacity after in vitro stimulation [133]. In contrast to 
our results, Puff et al found no difference in proportions of Tregs between 
sectio-delivered and vaginally born children through childhood [133]. Thus, 
further studies are needed to validate the observations above, and to establish 
how delivery by cesarean section influences adaptive immunity in children.  
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 Sex-related	differences		6.5
In the majority of developing countries, the mortality rate is significantly 
higher among boys than girls during the first 5 years in life, although they 
have equal access to food and medical care [134]. This is suggested to be a 
consequence of a higher vulnerability to infections among boys. Indeed, sex-
related differences in immune responses have been demonstrated for several 
cell subsets of both the innate and adaptive arm of the immune system in 
adults, and women generally mount stronger and more effective immune 
responses than men to viral and bacterial infections [135]. However, few 
studies have investigated sex-related differences in immune maturation 
during childhood.  
By using multivariate analyses, we have shown that adaptive immunity differ 
considerably between girls and boys during the first three years in life [132]. 
We show that being a girl is associated with higher proportions of CD45RO+ 
memory T cells at birth and in infancy, and also with mononuclear cells with 
a higher capacity to produce IL-13 and TNF at 4 months of age [132]. 
Additionally, girls have significantly lower proportions of Tregs than boys at 
birth and in infancy as well as lower proportions of naïve CD5+ B cells during 
the first 3 years in life [111, 132]. Girls also present with higher BAFF levels 
at birth compared to boys [111]. In all, our results indicate that girls have a 
more activated adaptive immunity in infancy and early childhood in 
comparison to boys. However, other studies show that boys mount higher 
PHA-induced IFN-γ responses at 1 year of age and higher IL-5 and IL-13 
responses at 3 years of age compared to girls [136], and that Treg frequencies 
do not differ between girls and boys in the first year of life [137]. 
Regarding lymphocyte counts, girls appear to have significantly higher 
numbers of CD4+ T cells in cord blood and also in the first year of life, while 
B cell numbers do not seem to differ between girls and boys at this age [132, 
138]. In line with others, we show that girls also mount greater antibody 
responses to certain vaccines [132, 139], which will be further discussed in 
section 8.3. In all, biological sex may be an important source for variations in 
early life immune maturation. However, further studies are needed in order 
to establish the observed associations between sex and early life immune 
maturation, and also to investigate the cause for these associations.  
  
Anna Strömbeck 
37 
 
7 VACCINATION	
Successful vaccination relies on the induction of an immunological memory 
that mediates protection from infection upon re-exposure to the pathogen. 
The concept of vaccination is believed to originate several hundred years ago. 
However, the major breakthrough in vaccination came in 1796 when 
Edward Jenner used cowpox as a vaccine against smallpox. This act was 
based on the observations that dairy maids who had suffered from cowpox 
were naturally protected from smallpox. Smallpox is the first infection that 
has been fought by vaccination on a global scale, and in 1980, almost 200 
years after Jenner’s initial experiments, smallpox was officially declared 
eradicated.  
In 1974, the World Health Organization founded the Expanded Program on 
Immunization to provide all children in all countries with protection against 6 
different infectious diseases, i.e. tuberculosis, diphtheria, tetanus, pertussis 
(whopping cough), measles and poliomyelitis, through routine vaccinations. 
Today, the global childhood immunization program recommends 
vaccination against 12 different pathogens [140], and the program is 
nationally designed to provide optimal protection in each country. A high 
vaccination coverage in a population is central for preserving the herd 
immunity, which offers protection also to unvaccinated individuals. In 
Sweden, 98-99% of all two-year-old children are immunized against 
diphtheria, tetanus and pertussis (the DTP-vaccine), and 95% have received 
vaccine against measles, mumps and rubella (the MMR-vaccine) [141]. 
During 2015, approximately 86% (116 million) of all infants in the world 
received complete DTP-vaccination. However, it is estimated that more than 
19 million infants throughout the world do not receive the recommended 
doses of basic vaccines [142]. 
As described in chapter 5, babies and young children are particularly 
vulnerable to infections, and protection against infections through efficient 
vaccinations is one of the most effective methods to reduce morbidity and 
mortality among children across the world. However, as a consequence of the 
neonatal immune immaturity, vaccine-induced immune responses in early life 
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are generally low and the efficacy hence limited. Additionally, as described in 
section 5.2, maternal IgG antibodies are passively transferred to the child 
during pregnancy in order to protect the child and attenuate infections during 
initial maturation of the immune system. Although maternal antibodies are 
very efficient in protecting the infant during the first months of life from 
infections already experienced by the mother; these antibodies may 
unfortunately also hamper vaccine-induced immune responses, which may 
further complicates neonatal vaccine strategies [143].   
 Different	types	of	vaccines	7.1
Vaccines can be classified into three major groups; live attenuated vaccines, 
inactivated vaccines, and subunit/acellular vaccines. Live attenuated 
vaccines comprise weakened versions of the pathogens that are still able to 
replicate and interact with the immune system in the host. This group 
includes vaccines against diseases caused by viruses, e.g. measles, mumps, 
rubella, and yellow fever, or by bacteria, e.g. tuberculosis. These vaccines are 
safe to use in healthy individuals but since these vaccine pathogens can 
replicate, they may cause severe or fatal reactions in individuals with 
immunodeficiencies, e.g. patients with common variable immune deficiency, 
leukemia, or HIV-infection.   
The second major group of vaccines, inactivated vaccines, can be 
composed of either killed whole viruses or bacteria, while the third major 
group, acellular or subunit vaccines, consist of purified subunits of the 
pathogens that in turn can be either protein- or polysaccharide-based. 
Further, there are also vaccines based on detoxified bacterial toxins (toxoid 
vaccines), which are used against bacterial diseases in which the toxins are the 
cause of illness, such as diphtheria or tetanus. All these vaccines lack the 
ability to replicate and are thus safe to administer also to individuals with 
immune deficiencies and will collectively be referred to as non-live 
vaccines in this thesis.  
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 How	do	vaccines	induce	protective	immunity?	7.2
As for any natural infection, the very first requirement for a vaccine to trigger 
an efficient immune response is to provide sufficient danger signals that 
trigger activation of the innate immune system. As live attenuated vaccines 
consist of whole viruses or bacteria, it is proposed that they activate innate 
immunity through several different PRRs, such as TLRs.  
Non-live vaccines may still contain PRRs that trigger an innate immune 
response. However, owing to the lack of replication, these vaccines induce a 
more limited immune activation as compared to live vaccines. Therefore, 
most non-live vaccines require formulation with specific adjuvants to trigger 
sufficient innate immune activation, and the choice of adjuvant will skew the 
immune response. Several compounds with adjuvant properties exist, and 
these compounds may be divided into two main categories based on their 
mechanisms of action: immune stimulatory adjuvants and delivery systems. 
Immune stimulatory adjuvants, e.g. agonists for various TLRs, trigger 
activation of APCs through different PRRs, which ultimately leads to 
adaptive immune responses. Delivery system adjuvants, such as the 
aluminum salt-based adjuvant alum and emulsion adjuvants, can function as 
carriers to which the vaccine antigens can be associated, and these types of 
adjuvants may also prolong the antigen deposit at site of injection and create 
local inflammatory responses. The adjuvant effect of alum was discovered 
almost a century ago, and alum is still by far the most widely used adjuvant. 
Previously, alum was thought to act only through depot formation at the 
injection site; today it is known that alum-based adjuvants have several effects 
that account for their adjuvant properties, which also includes direct immune 
stimulation. However, alum does not act via TLRs to activate innate 
immunity [144]. Instead, it is suggested that alum activates the NLRP3 
inflammasome, which results in release of the proinflammatory cytokine IL-1 
[145, 146]. Alum-based adjuvants preferentially induce TH2 cells that 
ultimately results in a robust antibody response [147]; yet, it remains unclear 
by which mechanisms alum induces TH2-responses.  
If the vaccine antigen with or without the addition of adjuvants exhibit 
sufficient danger signals, it will trigger activation of dendritic cells that 
migrate to the draining lymph nodes. The immune responses to live 
attenuated vaccines are virtually identical to that produced by a natural 
infection and include activation of both CD4+ and CD8+ T cells. However, 
since non-live vaccines cannot replicate, vaccine antigens are not presented 
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on MHC-I molecules; CD8+ T cells are thus generally neither generated nor 
needed. Yet, some dendritic cells have the ability to present ingested antigens 
on MHC-I to CD8+ T cells in the process of cross-presentation. As described 
in detail in section 4.2, activated CD4+ T cells provide crucial help to B cells 
that recognize the cognate antigen. This interaction results in generation of 
both long-lived plasma cells that produce high-affinity vaccine-specific 
antibodies as well as long-lived affinity-matured memory B cells, which is the 
ultimate goal of most vaccinations.   
Since T cells only recognize protein antigens, vaccines purely based on 
polysaccharide antigens fail to activate T cells. B cell responses to 
polysaccharide antigens do not include formation of germinal centers and are 
accordingly characterized by the induction of moderate levels of low-affinity 
IgM antibodies that wane after a few months and a lack of B cell memory. In 
the absence of immunologic memory, subsequent re-exposure to the same 
polysaccharide antigen elicit the same immune response in vaccinated as in 
non-vaccinated individuals [148] However, if polysaccharides are conjugated 
to a protein antigen, antigen-specific T cells become activated and provide 
help to the B cells. This will result in germinal center formation, high-affinity 
antibody producing plasma cells, and memory B cells.  
Almost all current vaccines work through induction of vaccine-specific 
antibodies, and antibodies in sufficient quantities are the predominant 
correlate of protection for most vaccines. For some vaccines, e.g. against 
diphtheria, tetanus, measles and rubella, a certain antibody level almost 
ensure protection. For other vaccines, however, infections may occur despite 
antibody titers above nominally protective levels [149].  
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8 DOES	BASELINE	IMMUNE	MATURATION	
AFFECT	VACCINE	RESPONSES?	
Although vaccine formulations and immunization schedules are similar in 
most countries, immune responses to certain vaccines differ significantly 
between populations across the globe [150]. The reasons underlying these 
variations are likely complex and may involve differences in practical 
handling of vaccines. For instance, vaccines generally need to be kept in a 
narrow temperature range from the point of manufacture to their use, and 
difficulties in keeping the cold-chain infrastructure in some geographical 
regions may contribute to population-based variations in vaccine responses. 
In addition, the impact of environmental exposures that may shape baseline 
immune maturation and activation prior to vaccination may also impact the 
magnitude and profile of vaccine-induced immune responses.  
 …to	live	attenuated	vaccines?		8.1
Although several studies show variations in vaccine-induced immune 
responses, few longitudinal studies have investigated whether baseline 
immune maturation and activation prior to vaccination is related to vaccine 
responses. It has been shown that young healthy adults in Uganda present 
with significantly lower vaccine-specific antibody titers in the circulation after 
vaccination with the live attenuated viral vaccine against yellow fever (YF-
17D), compared with age-matched vaccinees in Switzerland [151]. These 
differences were attributed to variations in immune maturation and 
activation status between the populations before the vaccination; the 
Ugandan population having a heightened activation of innate immunity, as 
well as increased proportions of memory T and B cells prior to vaccination 
[151]. These results indicate that a heightened baseline immunity before 
vaccination negatively affects vaccine responses to the live attenuated vaccine 
against yellow fever. In line with this, we have shown that higher proportions 
of circulating memory T cells and higher cytokine producing capacity of 
PBMCs prior to vaccination in early childhood is associated with lower 
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vaccine-specific antibody titers after vaccination with the live attenuated 
vaccine against measles, mumps, and rubella (MMR) in our prospective birth 
cohort study [132]. Also, higher proportions of Tregs, which has previously 
been linked to delayed adaptive immunity [64], was associated with increased 
vaccine-induced antibody responses [132]. Interestingly, 7 days after 
vaccination against yellow fever, the YF-17D viral load in plasma was 
strikingly lower in the Ugandan compared to in the Swiss population [151]. 
The authors thus speculate that the heightened baseline immunity prior to 
vaccination negatively affects vaccine responses, at least partly, by limiting 
viral replication in these individuals.  
In contrast to most vaccines, the live bacterial BCG-vaccine against 
tuberculosis does not mediate protective immunity by induction of vaccine-
specific antibodies; instead, BCG-induced T cells are the main effectors. The 
BCG-vaccine is administered at birth or soon after in many high-risk 
countries and, as with many other vaccines, the efficacy of the vaccination 
show large geographical variations. Interestingly, after BCG- vaccination, 
infants in Malawi develop T cells with a cytokine profile that is strikingly 
different from that of infants in the UK [152]. Upon in vitro stimulation of 
whole blood with purified vaccine-antigen 3 months after vaccination, cells 
from UK infants produced higher levels of IFN-γ and IL-2, whereas the cells 
from Malawi infants generally produced higher levels of TH2 related 
cytokines as well as higher levels of the regulatory cytokine IL-10 [152]. 
Indeed, TH1-related cytokines, such as IFN-γ, have been shown to be 
advantageous for immunity to tuberculosis, whereas overproduction of TH2 
and regulatory cytokines may impede immunity [153]. The authors speculate 
that the difference in cytokine response between UK and Malawi infants are 
most probably due to disparities in baseline immune maturation and 
activation prior to vaccination; and since the BCG-vaccine is administered to 
neonates or early in infancy, differences in pre- or perinatal environmental 
factors may be pivotal [152]. Indeed, as described in section 6.1, children in 
regions with a more traditional lifestyle show a higher degree of adaptive 
immune maturation already at birth as compared to children born in more 
industrialized regions of the world [91]. In all, these studies point to that live 
vaccines induce more efficient immune responses in hosts with a lower degree 
of immune maturation and activation prior to vaccination.  
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 …to	non-live	vaccines?		8.2
In contrast to live attenuated vaccines, a heightened baseline immune 
activation before vaccination seems to favor immune responses to the non-
live DTP-vaccine. In a randomized study, Turkish infants responded with 
markedly higher antibody production against all antigens in the DTP-
vaccine, as compared to Belgian infants [154]. Further, Senegalese infants 
who received the same batch of DTP-vaccine at corresponding ages, 
presented with vaccine-specific antibody titers in the same range as the 
Turkish infants [155]. Although factors associated with differences in vaccine-
induced antibody responses observed between populations were not 
investigated, the authors stress that there is a trend for higher immune 
response in less industrialized countries, i.e. Turkey and Senegal. The authors 
also here hypothesize that possible explanations may include differences in 
immune maturation and activation prior to vaccination. We obtained similar 
results in our Swedish prospective cohort, as we found that higher DTP-
induced antibody levels at 18 months of age were associated with lower 
absolute numbers of circulating T and B cells in infancy, which according to 
our study reflect a more mature adaptive immune system during childhood 
[89]. Also, a higher proportion of memory B cells prior to vaccination has 
been identified as a significant predictor of higher antibody responses to the 
non-live hepatitis B vaccine in adults [156]. However, if these associations are 
valid also for other non-live vaccines remains to be determined.  
 
Thus, in view of the studies discussed above, it appears as a heightened 
baseline immune maturation and activation prior to vaccination augments 
protective immune responses conferred by the non-live DTP-vaccine, but 
impede the efficacy of several live vaccines. The reasons for these differences 
are poorly understood, but it is likely that intrinsic differences in vaccine 
formulations between live and non-live vaccines and their respective way to 
induce immune responses are of importance. A heightened baseline immune 
maturation and activation, which for example is the concept of ‘trained 
immunity’ described in section 2.2, is characterized by improved 
responsiveness to antigen-stimulation with increased production of 
inflammatory mediators and an enhanced capacity to eliminate pathogens. 
Thus, similarly to natural infections, a more efficient host immunity could 
possibly combat the pathogens of live viral vaccines before an efficient 
immune response has been elicited. However, since the immunogenicity of 
the non-live DTP-vaccine rather relies on alum as an adjuvant, it is plausible 
that a heightened baseline immune maturation and activation do not 
Anna Strömbeck 
44 
 
interfere with its mechanisms of action, but rather enhances it. Although 
other factors than baseline immune maturation may influence vaccination 
outcomes, the results discussed above point to that further studies of 
associations between baseline immune maturation and responsiveness to 
different vaccines may be of great importance for the development of new 
vaccination strategies.  
 Genetics	and	sex	as	determinants	of	vaccine	8.3
responses		
In addition to baseline immune activation, other factors may also influence 
vaccine-induced immune responses. It has been proposed that genetic 
polymorphisms play a substantial role in the variation of vaccine-induced 
antibody levels [157, 158]. Genetic variations can occur via polymorphisms 
of genes involved directly or indirectly in the generation of immune 
responses, e.g. genes encoding various pathogen receptors, cytokines, 
cytokine receptors, MHC-II molecules, and many other structures.  
Further, there are clear sex-related differences in vaccine-induced 
immune responses among both children and adults. In general, females 
mount stronger antibody responses than males in response to both live 
attenuated and non-live vaccines [139, 159]. Specifically, higher vaccine-
induced mumps and rubella antibody titers have been reported in blood from 
adolescent girls compared to boys in the same age [160, 161]. This 
observation was also confirmed among children in our prospective cohort, 
since girls presented with significantly higher vaccine-induced mumps and 
rubella antibody titers at 36 months of age [132]. Whether sex-related 
differences in antibody responses to vaccines are caused by genetic, hormonal 
or environmental factors, or a combination, remains to be established.  
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9 SENSITIZATION	AND	ALLERGIC	DISEASE	
A top priority for the immune system is to mount an effective defense against 
pathogenic microorganisms. In parallel, it needs to avoid aggressive immune 
responses to self-antigens; this is primarily managed in thymus by the 
mechanism of central tolerance, as described in section 3.1. In addition, the 
immune system should also tolerate encounters with the infinite number of 
harmless antigens that are present in food and in the surrounding 
environment, here referred to as allergens. This is accomplished by the 
mechanism of peripheral tolerance. Upon antigen/allergen-recognition 
without adequate co-stimulation from APCs, the T cell does not become 
activated. Instead, the T cell receptor may lose its ability to transmit 
activating signals and the cell becomes anergic; a second fate includes death 
by apoptosis. However, some T cells may also develop into Tregs that 
suppress proliferative and cytokine responses against the allergen.  
These tolerance mechanisms do however fail in some individuals, which 
results in activated T cells that trigger B cells to produce allergen-specific 
IgE antibodies to these harmless allergens, which is referred to as 
sensitization [162]. In some sensitized individuals, these antibodies can 
further trigger inflammation upon renewed exposure to the allergen, giving 
rise to immune-mediated hypersensitivity, i.e. allergy. It is still not known 
why some individuals mount allergen-specific IgE-antibodies or why re-
exposure to allergens cause allergic reactions in some but not all sensitized 
individuals. 
Although sensitization can occur without symptoms of allergic disease, there 
is a strong association between these two conditions. Children who are 
sensitized to any allergen at 18 months of age but without any allergic 
symptoms, have a higher risk than non-sensitized children to develop 
symptoms of wheezing, asthma and rhinitis at 5 years of age [163]. The 
prevalence of sensitization increases with age; 13% at 1.5 years, 50% at 5 
years, and 61% at 26 years of age, according to a prospective cohort 
published in 2013, where Danish subjects were followed from birth to early 
adulthood [164]. In this cohort, the children were primarily sensitized to food 
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allergens during the first 5 years of life, whereas sensitization to house dust 
mites and pollen dominated in school age and adulthood [164].  
 Sensitization	upon	first	encounter	with	the	allergen		9.1
The sequence of events in the allergic reaction begins with the capture of 
allergens by APCs, primarily dendritic cells, at mucosal surfaces. Allergens 
have the capacity to prime dendritic cells for TH2-induction by engaging an 
array of surface receptors, for example TLRs [165, 166]. The primed 
dendritic cells migrate to the nearest lymphoid tissue where they present 
processed peptides from the allergen to naïve T cells (see section 3.2 for a 
more detailed description of the T activation process). If the naïve T cell 
recognizes the peptide and is exposed to IL-4 it will be stimulated to 
differentiate into a TH2 cell.   
 
In parallel, intact allergens will be transported by the lymphatics to the 
lymphoid tissue where it can be recognized by B cells with the right receptor 
specificity. As for any protein-antigen, primed B cells are activated through 
interactions with cognate TH cells. Secretion of IL-4 and IL-13 by TH2 cells 
or TFH cells activated by the same allergen, stimulates allergen-specific B 
cells to class switch to IgE production. In addition, it was recently 
shown that allergen-specific B cells are essential for optimal expansion and 
activation of the allergen-specific TH2 cells [167]. 
 
The allergen-specific IgE antibodies bind to high-affinity Fcε-receptors 
expressed on mast cells, which reside in connective tissue, especially below 
epithelia and next to blood vessels. IgE antibodies also bind to circulating 
basophils. Thus, in sensitized individuals, mast cells and basophils are 
coated with IgE-antibodies specific for the allergen to which the person is 
sensitized. Importantly, as also mentioned above, the presence of allergen-
specific IgE antibodies in blood does not mean that the person is allergic; in 
many cases, sensitized individuals do not have any clinical symptoms.  
Tests	for	IgE	sensitization	
IgE sensitization can be diagnosed by sensitive detection of allergen-specific 
IgE antibodies in blood, by skin prick test, and by basophil activation test. A 
skin prick test is usually performed by placing a drop of the allergen extract 
solution on the skin, usually on the forearm. The skin beneath the drop is 
then pricked with a thin needle. If the subject has allergen-specific IgE 
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antibodies bound to the surface of mast cells in the skin, this will lead to 
activation of the mast cells and immediate release of inflammatory 
substances, such as histamine, as further described in section 9.2 below. This 
elicits a small local allergic response with swelling and redness in the skin at 
the site of testing. As mentioned above, similar to mast cells, basophils express 
surface receptors for IgE. The basophil activation test is a flow cytometry-
based assay where expression of activation markers on basophils is measured 
after in vitro stimulation with allergen.  
 The	allergic	reaction	9.2
In some of the sensitized individuals, an allergic reaction is triggered by the 
activation of mast cells upon re-encounter with the specific allergen to 
which the individual is sensitized. Activation occurs when two or more IgE 
antibodies on the cell surface of mast cells are crossed-linked by the specific 
allergen. This activation triggers rapid release of granules containing 
histamine and proteases, which gives rise to an ‘immediate allergic 
reaction’. Histamine activates endothelial cells, which leads to increased 
vascular permeability and dilatation of small blood vessels, whereas 
proteases may cause local tissue damage. Histamine also stimulates 
transient contraction of smooth muscles.  
The ‘immediate allergic reaction’ is followed by a ‘late phase reaction’, 
which can develop and last for hours after allergen encounter. This reaction is 
mediated and maintained by synthesis and secretion of prostaglandins and 
leukotriens, and also by synthesis and secretion of various cytokines and 
chemokines. Similarly to histamine, prostaglandins and leukotriens 
increase vascular permeability and stimulate smooth muscle contraction, but 
the effects are more potent and last longer. In addition, these mediators 
also stimulate mucus secretion and promote influx and activation of 
leukocytes in the tissue.  
A hallmark of the IgE-mediated inflammatory response is the recruitment 
of leukocytes from the circulation, e.g. eosinophils, neutrophils and 
TH2 cells, into the tissue. This recruitment is mediated by IL-4, IL-5 and 
TNF produced by TH2 cells and mast cells and induce endothelial cells to 
upregulate the expression of adhesion molecules, which in turn promote 
extravasation of circulating leukocytes. Recruitment of circulating immune 
cells is also mediated by chemokines produced by tissue resident macrophages 
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and by T cells that has infiltrated the inflamed tissue, and also by endothelial 
cells.  
Eosinophils contain several different types of granule proteins that exhibit 
both tissue-damaging/remodelling as well as immune-modulatory activities. 
Despite that the allergic inflammation is characterized by tissue infiltration by 
eosinophils and eosinophilia in the blood, the full role of these cells in allergic 
inflammations is not yet understood.  
The physiological effects of the allergic reaction differ considerably depending 
on which tissue is affected. For example, hay fever and asthma are symptoms 
from the upper and lower respiratory tract, respectively, and are caused by 
inhalant allergens, such as those derived from pollen and animal dander. 
Food allergy can be manifested by allergic reactions in the gut with increased 
fluid secretion and peristalsis followed by vomiting and diarrhea, but may also 
manifest as urticaria in the skin.  
 The	atopic	march		9.3
The term ‘atopic march’ describes the natural history of sensitization to 
allergens and symptoms of allergic disease that may develop during a certain 
period in childhood; some symptoms may persist over several years, whereas 
other show a more rapid spontaneous remission with age [168]. Atopy is 
defined as a personal or familial predisposition to become sensitized, and thus 
to produce IgE antibodies in response to harmless ingested or inhaled 
allergens. As described in the beginning of this chapter, some sensitized 
individuals also develop symptoms of allergic disease, such as eczema and 
asthma; in sensitized individuals, these symptoms may also be referred to as 
atopic asthma, atopic eczema and so forth. Important to note in this section is 
that the prevalence rates of allergic diseases may differ considerably between 
studies, which can be explained by differences in definitions and criteria used 
for diagnoses as well as differences between the populations studied.  
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 Diagnoses	of	allergic	disease	in	children	9.4
Eczema	
Eczema is generally a very early clinical manifestation of atopy in a child and 
the debut is before 6 months of age in half of all affected children [164, 169]. 
The prevalence of eczema in children peaks at around 15% during the first 
years of life, and thereafter decreases with age [164, 170]. The criteria for 
diagnosis of atopic eczema includes itchy skin conditions in the past 12 
months, generally dry skin in the past year, visible flexural dermatitis, and 
onset of symptoms before 2 years of age [171]. The risk of other allergic 
diseases, primarily asthma and hay fever is markedly increased in children 
with eczema [172], and it has been suggested that a defect in epithelial 
barrier integrity caused by eczema may increase the exposure to allergens, 
which may contribute to an increased risk of allergy development.  
Food	allergy	
Around one third of all children with atopic eczema also report to have skin 
symptoms provoked by food allergy [173]. Food allergy occurs very early in 
childhood or infancy, and symptoms can range in severity from mild to life 
threatening. Exposure to very small amounts of food allergens can trigger 
clinical symptoms such as urticaria, eczema and bouts of vomiting and 
diarrhea, as well as airway inflammation. More than 170 food items have 
been reported to cause IgE-mediated allergic reactions, but the allergens most 
commonly involved are proteins from cow’s milk, hen’s egg, tree nuts, 
peanuts, fish and shellfish.  
As mentioned in the beginning of this section, the estimated prevalence of 
allergic disease in children differs considerably between studies, and this 
applies particularly well to the reported prevalence of food allergies. In 
addition to differences in criteria and study populations, self-reported 
prevalence of food allergy is known to be vastly overestimated. However, it 
has been suggested that the prevalence of food allergy diagnosed by health 
care peaks at around 5-7% within the first 2 years in life and then drop with 
age [164, 174]. Around half of all children with IgE-mediated allergy to milk, 
egg, soy or wheat outgrow their allergy during childhood, whereas allergies to 
other foods, e.g. peanuts and tree nuts are more likely to persist for life [175].   
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Asthma	
The airways are an important route for allergen entry, and IgE-mediated 
allergic asthma, simply referred to as asthma in this thesis, is an allergic 
reaction in the lower airways. In asthmatic individuals, allergen exposure to 
the airways can lead to bronchial constriction within seconds, as well as an 
increased secretion of fluid and mucus that makes breathing even more 
difficult by trapping inhaled air in the lungs. The incidence rate of diagnosed 
asthma peaks at 1-2 years of age [174, 176], and symptoms start before 8 
years of age for 90% of all asthmatics. The prevalence of asthma in children 
is highly dependent on age and geographic location, but is estimated to 
approximately 10-20% [164, 172, 174]. 
Allergic	rhinoconjunctivitis	
Allergic rhinoconjunctivitis is a reaction to airborne allergens deposited on 
the mucosal membrane inside the nose in rhinitis, and eyes in conjunctivitis, 
and is generally considered as the last step of the atopic march. Symptoms 
include stuffy and runny nose, sneezing, redness and swelling of the eyelids 
and increased production of tears. Allergic rhinoconjunctivitis typically 
develop later in childhood and the prevalence is estimated to 15% in 
adolescents and 30% in young adults [164].  
 Allergy	–	genetics	or	environment?	9.5
Allergic diseases have a complex etiology, and appear to be caused by an 
interplay between genetic factors and environmental exposures. It has been 
shown that parental allergic disease is the strongest risk factor for allergy 
development in the offspring. Thus, the genetic component is of major 
importance, and the heritability has been estimated to vary between 71-84% 
for eczema, 33-91% for allergic rhinitis, and between 35-91% for asthma 
[177]. Variations within numerous different genes appear to contribute to this 
strong genetic component, but the mechanisms by which these genes 
influence the development of allergies are still poorly understood [177]. 
The prevalence of allergic disease during early childhood is generally higher 
among boys compared to girls [81, 178, 179]. It has been suggested that 
the higher rate of asthma in boys could be a result of their smaller airways 
relative to lung size as compared to girls [180]. However, a more immature 
adaptive immunity among boys compared to girls in early childhood could 
also contribute to a higher prevalence of allergic disease among boys [111, 
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132, 135]. During adolescence, there is however a shift, with asthma 
becoming more common in girls [181].   
In addition to genetic predisposition and sex, epidemiological studies have 
emphasized many associations between early life environmental exposures 
and subsequent risk for allergy development. For instance, an altered 
gut colonization pattern during infancy has been associated with subsequent 
development of various allergic diseases in several studies. Specifically, a low 
gut microbial diversity in infancy has been associated with eczema in children 
up to two years of age [182, 183], and with asthma in school-age children 
[184]. This association has been proposed to be a consequence of that a less 
complex gut flora fails to induce sufficient immune stimulation to support 
normal maturation of the immune system. In line with this, it has been shown 
that the prevalence of eczema and asthma is strongly reduced in children 
whose parents consistently clean their pacifier by sucking it [185]. The 
authors speculate that this observed protective effect of parental pacifier 
sucking is due to transfer of parental oral bacteria to their infant.   
Identified allergy-protective environmental factors include large 
family size and having elder siblings [186, 187] (further described in section 
10.1), increased diversity of food introduced in the first year of life [188] and 
pet ownership [187, 189]. Moreover, growing up in a traditional farming 
milieu confers a strong protection from development of allergic diseases. 
Indeed, the farming milieu is the most potent allergy-protective 
environmental factor known in affluent industrialized countries. 
 The	allergy	protective	effect	of	farming	9.6
environments		
One of the first studies that tested the hypothesis of an allergy-protective farm 
effect was a cross-sectional study published in 1999, which demonstrated that 
farming as a parental occupation was associated with lower prevalence of 
sneezing attacks during pollen season as well as with lower prevalence of IgE-
sensitization to outdoor as well as indoor allergens [190]. Interestingly, this 
study further showed a gradient in sensitization from non-farming to full-time 
farming as parental occupation, suggesting a dose-response effect [190]. 
Shortly after this, these associations were confirmed by other cross-sectional 
studies, and evidence of a protective effect of farming environments also on 
asthma and wheeze was added [191, 192]. These studies further showed an 
Anna Strömbeck 
52 
 
association between regular contact with livestock and reduced risk of 
sensitization and allergic disease among the children [191, 192]. Since then, 
numerous large cross-sectional studies around the world have examined and 
confirmed the protective effect of a farming environment on development of 
sensitization and allergic diseases in childhood [193].  
 
Although these epidemiological studies provide overwhelming evidence for 
this protective farm effect, the characterization of the protective components 
as well as the optimal timing for exposure are far from being understood, 
because most of these studies were of a cross-sectional design and included 
school-aged children. However, some of the identified farm-related 
exposures that independently contribute to the reduced risk of developing 
allergic disease among farmers’ children are regular contact with livestock 
and animal feed as well as consumption of unpasteurized cow’s milk [104, 
105, 194]. Of note, the timing of exposure was crucial, since the strongest 
protective effects were found when exposed prenatally or during the first year 
of life [104, 194].  
As described in section 6.2, environmental exposure to microbial products, as 
measured by endotoxin levels, are significantly higher in homes of farming- 
compared to non-farming families [99, 100]. Increased endotoxin exposure is 
associated with a significantly lower risk of asthma, hay fever, and IgE-
sensitization in childhood [100]. As mentioned in section 6.2, the endotoxin 
levels in airborne dust differ significantly between homes of the two farming 
populations Amish and Hutterite, who practice a more traditional compared 
to a more industrialized farming, respectively [101]. Indeed, the prevalence of 
asthma also differed significantly between these two groups of children; none 
of the 30 Amish children in the study reported symptoms of asthma, whereas 
6 (20%) of the Hutterite children did [101]. This is in line with previous 
studies that show associations between high exposure to endotoxins and low 
prevalence of asthma. As described above, a traditional farming environment 
is associated with an environment with a high microbial antigen diversity. 
Thus, increased exposure to microbes and microbial products, which may be 
reflected by higher endotoxin levels, may stimulate enhanced immune 
maturation that could lead to a reduced risk of allergy among farmer´s 
children. 
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10 	IMMUNE	MATURATION	IN	RELATION	TO	
SENSITIZATION	AND	ALLERGIC	DISEASE	
 The	hygiene	hypothesis		10.1
A striking increase in the prevalence of allergic conditions has occurred 
during the second half of the twentieth century [195-198]. Since this rapid 
increase cannot be explained by genetic alterations, and many of the children 
who become allergic do not have allergic parents, other factors must account 
for this increase. Today, allergy is the most common chronic disease in 
children and adolescents in westernized affluent countries. At the age of 5, 
approximately one third of all children in Sweden and Denmark are or have 
been affected with one or more allergic manifestations [176]. This dramatic 
increase, in combination with large variations in the worldwide prevalence of 
allergic diseases, suggest a strong impact of environmental factors on allergy 
development.  
The publication of David Strachan in 1989 is regarded as the starting point 
for the research regarding the environmental influence on allergy 
development in children. In a prospective birth cohort, including almost 
17,500 British children, Strachan found that the prevalence of self-reported 
hay fever during childhood was inversely related to the number of older 
siblings [186]. Strachan hypothesized that infections, prenatally or in early 
childhood, ‘transmitted by unhygienic contact with older siblings’, might 
prevent the development of allergic diseases in childhood; this was the origin 
of the ‘hygiene hypothesis’. Over the last decades, new angles and aspects of 
environmental effects on development of allergic diseases in children have 
been proposed with the hygiene hypothesis as basis, and the role of viral or 
bacterial infections as well as the impact of exposure to non-viable microbial 
products on the innate and adaptive immune system have been explored 
[199]. Although a wide range of possible allergy-protective exposures, the 
core of the hygiene hypothesis remains, namely that reduced exposure to 
microbes or microbial products early in life may lead to delayed adaptive 
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immune maturation and as a consequence development of allergic disease. 
However, the relationship between postnatal adaptive immune maturation 
and allergic disease has not yet been established. 
 CD4+	T	cells	 10.2
As described previously, ongoing allergic inflammation is generally 
characterized by excessive TH2 immune responses with increased production 
of TH2 related cytokines, such as IL-4, IL-5 and IL-13. This was also 
observed in our prospective study, since current allergic disease at 3 years of 
age was associated with higher mitogen-induced production of IL-5 and IL-
13 by PBMCs [76].  
However, the relation between early life cytokine producing capacity in 
general prior to development of allergic diseases is not established. Regarding 
TH2-related cytokines, some studies show a strong association between 
increased proportions of IL-4+CD4+ cells upon polyclonal in vitro stimulation 
of cord blood and development of allergic disease in early childhood [200, 
201], while others do not [202]. Furthermore, a higher production of IL-13 
upon polyclonal stimulation of PBMCs at 3 months of age, but not at birth, 
was strongly associated with subsequent development of both atopic and non-
atopic asthma between 1 and 5 years of age in a birth cohort study 
comprising 450 US children [68].  
Regarding TH1-related cytokines, it has been shown that children with 
lower proportions of IFN-γ producing CD4+ T cells after polyclonal 
stimulation of cord blood, had a fivefold higher risk to develop allergic disease 
during the first 2 years in life [201]. This result was obtained after adjustment 
for potential confounders, such as parental history of atopy, sex, pet 
ownership and maternal smoking during pregnancy [201]. Thus, this 
indicates that hampered IFN-γ production at birth is associated with 
subsequent development of allergic disease, which could be due to both 
genetic and prenatal environmental factors. Several other studies also 
demonstrate an association between impeded IFN-γ production at birth and 
subsequent allergic disease [202-204]. In some reports, however, these two 
factors were unrelated [68, 200, 205]. Nevertheless, an attenuated in vitro 
induced IFN-γ production in the first year of life is strongly associated with 
subsequent development of sensitization and/or allergic disease later in 
childhood and in early adolescence [68, 206, 207]. Although several studies 
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suggest that a TH2-skewed immune response in infancy precede allergic 
disease in children, the biological mechanisms behind these associations are 
probably very complex. Not only an excessive TH2 or impaired TH1 
response, but rather an imbalance between these two immune profiles early 
in life may influence the risk for later development of allergic disease.  
An impaired responsiveness to polyclonal stimulation early in childhood has 
been suggested to indicate an immaturity in the T cell compartment. In 
addition to attenuated IFN-γ responses, the immaturity in neonatal T cell 
function in children who go on to develop allergic disease may also include 
hampered proliferative capacity. For instance, the lymphoproliferative 
responses upon polyclonal stimulation of cord blood cells are significantly 
hampered in neonates who subsequently develop allergic disease [208], as 
well as in neonates with a high risk of developing allergic disease, i.e. both 
parents atopic, compared to low-risk neonates, i.e. both parents non-atopic 
[209]. Interestingly, parental atopy was not predictive for proliferative 
responses at 1 year of age, since there were no difference between the two 
groups of children at this age [209]. According to the authors, this indicates 
that genetic factors are of less relevance for the T cell responses at 1 year than 
at birth and that these responses instead may correlate with environmental 
exposures. In line with the hypothesis that a more immature T cell 
compartment in infancy may predispose for allergic disease, our prospective 
birth cohort shows that higher proportions of naïve CD45RA+ cells among 
CD4+ T cells in infancy is associated with allergic disease at 8 years of age 
(Strömbeck et al in manuscript: paper IV in this thesis).   
10.2.1 Regulatory	T	cells				
Since Tregs have suppressive effects on both B cells [210, 211] and T cells 
[16, 27, 77], these regulatory cells play a master role in controlling adaptive 
immune responses. One could thus hypothesize that Tregs are central for 
preventing development of sensitization and allergic disease in children. 
Significant efforts have been made to identify the role played by Tregs in the 
development of allergic sensitization and disease; however the vast majority of 
these studies have focused on adults or on children with established allergy. 
Since allergic symptoms often occur in the first years of life, studies of 
neonatal and infantile Tregs and subsequent development of sensitization and 
allergic disease are of significant interest. However, studies with this 
prospective design are few and results are inconsistent. This inconsistency 
may, as described in section 6.2.2, in part confer to different phenotypic 
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characterization of Tregs in these studies, as well as differences in 
experimental settings when assessing the suppressive function of these cells.   
A longitudinal study showed that the suppressive capacity of cord blood 
Tregs on lymphoproliferative responses did not differ between children who 
developed allergic sensitization or disease at 1 or at 2 years of age [212]. At 
one year of age, however, children who were sensitized or became sensitized 
within one year had Tregs with a reduced suppressive capacity, a difference 
that was not detectable at two years of age [212]. It has further been shown 
that neonates who developed allergy at one year of age had cord blood Tregs 
with reduced capacity to suppress IFN-γ production compared to neonates 
who did not develop allergy [213]. This effect was specific only for IFN-γ 
with no effects on other cytokine responses [213]. Further, studies differ 
regarding suppressive function of Tregs in cord blood of children with a high 
risk of developing allergic disease, i.e. babies born by atopic mothers; one 
study showed that maternal atopy was associated with an impaired Tregs 
suppressive capacity in the baby [214], whereas another study found no such 
association [200]. A reduced suppressive capacity of neonatal Tregs could be 
a logical contributing factor to the failure of normal tolerance mechanisms. A 
reduced suppressive capacity of Tregs among children who later become 
sensitized or allergic could be a further indication of delayed adaptive 
immune maturation in children at high risk of developing allergic disease. 
However, since longitudinal studies are few and the outcomes vary, further 
research is required to establish the relationship between Treg function and 
subsequent development of sensitization and allergic disease.  
Additionally, it has been shown that lower numbers of Tregs in cord blood is 
associated with a higher risk of developing eczema and sensitization at 1 year 
of age [215]. Other studies report that the proportions of Tregs in cord blood 
do not differ between children who develop allergic sensitization or disease 
later in childhood and children who do not [212, 213]. In a prospective 
cohort of Australian children, it was shown that children who developed 
sensitization and/or allergic disease at 2 years of age had significantly higher 
proportions of circulating Tregs compared with non-allergic children at 6 
months of age [207]. This was observed for multiple atopic outcomes, i.e. 
sensitization to food and inhalant allergens as well as for eczema [207]. This 
association could be due to that proportions of Tregs may expand as a 
protective mechanism during an allergic inflammatory response, as observed 
in children with current sensitization or allergic disease, but also in other 
chronic inflammatory conditions [108, 212]. However, to rule out this as an 
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explanation for the observed associations between higher proportions of 
Tregs prior to development of sensitization and allergic disease, children who 
already had eczema at 6 months of age were excluded from the analysis. 
Exclusion of these children did not alter the outcome of the analysis, and 
additional regression analyses demonstrated strong associations between high 
proportions of Tregs and subsequent sensitization [207]. These associations 
were confirmed in our prospective birth-cohort study, since we found that 
children who became sensitized in the first three years of life had significantly 
higher proportions of circulating Tregs in the neonatal period compared to 
non-sensitized children [76]. In the follow-up study of the same cohort, we 
further found that allergic disease at 8 years of age is associated with higher 
proportions of Tregs from infancy throughout childhood (Strömbeck et al in 
manuscript: paper IV in this thesis). We also found that children with current 
disease at 8 years of age had significantly higher proportions or circulating 
Tregs, thus confirming results from previous studies mentioned above [108, 
212]. We speculate that higher proportions of Tregs early in life may impede 
adaptive immune maturation, which in turn could favor development of 
allergic disease. Still, additional prospective studies in larger birth cohorts are 
required to confirm that higher proportions of Tregs precede development of 
sensitization and allergic disease in children. Due to the inherent obstacles to 
collect human tissue samples, all studies above have investigated total Treg 
numbers or frequencies in the circulation. This is important to consider when 
interpreting the results, since lower Treg numbers or proportions may be a 
consequence of migration of these cells into target tissues where they execute 
their suppressive functions.  
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 B	cells	10.3
Although B cells are the precursors of IgE-producing plasma cells and, hence, 
key players in allergic disease, the relationship between early life B-cell 
maturation and subsequent allergy development has just started to be 
explored. To the best of our knowledge, our prospective FARMFLORA 
cohort is the first study that demonstrates that higher proportions of 
immature/naïve CD5+ B cells already at birth but also throughout childhood 
is associated with allergic disease in school-age children (Strömbeck et al in 
manuscript: paper IV in this thesis). We also demonstrate that a higher 
proportion of CD5+ B cells at 1 month of age is, indeed, a risk factor for 
subsequent development of allergic disease [81] (and Strömbeck et al in 
manuscript: paper IV in this thesis). In addition, low BAFF levels at birth are 
associated with higher proportions of CD5+ B cells and allergic disease in 
early childhood [81]. In this study, current allergic disease was associated 
with higher proportions of circulating immature/naïve and 
immature/transitional B cells (Strömbeck et al in manuscript: paper IV in this 
thesis); this is in accordance with others who have demonstrated that allergic 
adults have higher proportions of circulating immature/transitional B cells 
compared to non-allergic subjects [216, 217].  
The finding of a more immature B cell compartment in children with a 
higher risk of allergy is supported by a recent study of pregnant women with 
allergic asthma. In this study, there is a strong association between higher 
proportions of circulating transitional B cells during pregnancy and allergy 
development in the offspring at the age of 6 months. In addition, the 
proportion of transitional B cells in these women could be used as a predictive 
marker for allergy development in their offspring [217]. However, most 
allergic diseases arise after 6 months of age and these preliminary results need 
to be confirmed also at older ages. Yet, these results collectively provide 
further support to studies suggesting that delayed adaptive immunity may 
predispose for allergic diseases later in childhood.  
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CONCLUDING	REMARKS	
Adaptive immune maturation comes with age and is likely the result of a 
complex interplay between both intrinsic and numerous environmental 
factors, as pointed out through this thesis. However, surprisingly little is 
known regarding this adaptive immune maturation progress and its 
association with development of allergic disease and vaccine-responsiveness in 
children. In the FARMFLORA-study we have had the unique opportunity to 
prospectively follow children from birth throughout childhood, and we have 
performed detailed immunological analyses of blood samples obtained at 
several occasions. By the use of multivariate factor analyses we have, for the 
first time, been able to visualize longitudinal patterns of adaptive immune 
maturation in relation to clinical outcomes, i.e. sensitization and allergic 
disease, as well as in relation to certain environmental factors and 
immunologic effector responses.  
The rapid increase in the prevalence of allergic diseases in affluent countries 
in the last half-century points to an essential role of environmental factors in 
the development of these conditions. Although the hypothesis that 
compromised immune maturation during early childhood could increase the 
risk of allergic disease was introduced almost 30 years ago, the relationship 
between postnatal adaptive immune maturation and allergic disease has not 
yet been established. When analyzing associations between T cell maturation 
and sensitization up to 3 years of age in paper I, we found that, of all 
immunological parameters analyzed, the strongest association was observed 
between higher proportions of neonatal Tregs and subsequent sensitization. 
Indeed, children who were sensitized at 18 and/or 36 months of age had 
significantly higher proportions of Tregs within the circulating CD4+ T cell 
population at birth and early in infancy as compared to children who 
remained non-sensitized. In the 8 years follow-up study, presented as paper 
IV, we further show that higher proportions of Tregs during childhood was 
associated with allergic disease at 8 years of age. It is important to emphasize 
that our results are based on proportions of Tregs among CD4+ T cells in the 
circulation and not in the tissues where they execute there suppressive 
functions. Higher proportion of Tregs in the circulation could be a 
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consequence of a lower degree of migration of these cells into target tissues, 
but could also reflect a higher proportion of these cells among CD4+ T cells 
in general. Thus, it is somewhat difficult to interpret these results and to 
speculate on the immunological consequences of higher proportions of these 
cells in the circulation in early childhood. However, our results do not 
support the hypothesis that higher proportions of Tregs in childhood is 
protective against development of allergic disease. Instead, a high proportion 
of these cells early in life may hamper activation and maturation of the 
adaptive immune system, which in turn may predispose for development of 
allergic disease. Paper IV further shows that allergic disease at 8 years of age 
is associated with higher proportions of naïve CD45RA+ T cells in infancy as 
well as with higher proportions of immature/naïve CD5+ B cells from birth 
up to 8 years of age. Thus, according to our study, allergic disease in 
childhood is preceded by a heightened immaturity among circulating CD4+ 
T cells and B cells.  
Growing up in a traditional farming environment is the most potent allergy-
protective environmental factor known in westernized countries. Indeed, in 
paper IV we show that the incidence of allergic disease was significantly 
lower amongst farmers’ compared to non-farmers children during the first 8 
years in life, even in our small cohort. Interestingly, in paper I we found that 
a farming environment was strongly associated with lower proportions of 
circulating Tregs up to 3 years of age. This association did, however, not 
appear as strong later in childhood. Instead, paper IV shows that of all 
parameters analyzed during the first 8 years of life, growing up in a farming 
environment was most strongly associated with higher proportions of memory 
B cells as well as with lower proportions of naïve B cells at 8 years of age. 
Thus, growing up in a farming environment seems to be associated with a 
higher degree of immune maturation, which also may explain the lower 
incidence of allergic disease among these children. However, these results 
need to be confirmed in larger birth-cohort studies before any vast 
conclusions can be drawn. The traditional farming environment provides an 
environment with a high microbial antigen diversity. It is likely that this 
diversity contributes to increased immune stimulation and, as a consequence, 
a higher degree of adaptive immune activation and maturation in these 
children. A deeper understanding of the relevant stimuli to provide an 
efficient immune maturation may ultimately pave the way for development of 
effective strategies for prevention of allergic disease in children.   
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The impact of intrinsic and environmental factors that may shape immune 
maturation may also be central for how children respond to vaccination. In 
paper II and III, we show that baseline immune maturation and activation 
prior to vaccination is associated with the magnitude of vaccine-induced 
immune responses in children. In paper II, we investigated associations 
between adaptive immune maturation and DTP vaccine-induced antibody 
levels at 18 months of age. The most striking association pattern displayed for 
all three vaccines included was that higher vaccine-specific antibody levels 
were associated with lower absolute numbers of B cells and CD4+ T cells the 
first months in life. Further analyses showed that absolute numbers of CD4+ 
T cells correlated with proportions of naïve α4β7+ T cells, but correlated 
inversely with proportions of CD45RO+ memory T cells, at several occasions 
in childhood. A similar association pattern was observed for infant B cell 
counts. Thus, in this study, a higher lymphocyte count in infancy appears to 
reflect a more immature/naïve adaptive immunity in childhood. In all, this 
indicates that a heightened baseline immune maturation and activation prior 
to vaccination enhances protective antibody responses conferred by the non-
live DTP-vaccine in Swedish children. An opposite trend was however 
observed for antibody responses against the live attenuated MMR-vaccine 
(paper III). Higher vaccine-induced antibody titers were generally 
associated with a lower degree of adaptive immune maturation prior to 
vaccination. The reasons behind these differences are not fully understood, 
but one possible explanation lies within the intrinsic differences in vaccine 
formulations of the DTP- and the MMR-vaccine, and hence their respective 
way to induce immune responses in the host. Although other factors than 
baseline immune maturation prior to vaccination might be central for 
vaccination outcomes, our results indicate that further studies in this area are 
needed. A greater understanding of the relation between immune maturation 
and vaccine responsiveness may be of great importance for developing better 
vaccination strategies.  
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